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Malaria is a severe febrile illness caused by parasites of the genus Plasmodium, with nearly 
half of the world’s population at risk from infection. Severe malaria anemia (SMA) is one of 
the most common causes of mortality arising from infection with Plasmodium falciparum. 
Malaria is also associated with elevated levels of pro-inflammatory cytokines and the 
combination of exacerbated inflammatory responses with sequestration of parasites in host 
organs can also lead to other fatal complications such as cerebral malaria. While single 
nucleotide polymorphisms in the human CISH (cytokine inducible SH2 containing protein) 
gene have been associated with susceptibility to severe manifestations of malaria infections, it 
is not known if this susceptibility is due to altered erythropoiesis leading to anemia or 
exacerbations to cellular and cytokine responses that result in other severe outcomes such as 
cerebral malaria.  
The availability of Cish knockout mice and the ability to study anemia and cerebral 
malaria caused by the rodent malaria species P. berghei using mouse models of infection has 
enabled examination of whether CISH deficiency increases the susceptibility of mice to 
succumb to anemia or cerebral malaria in response to infection. In this thesis, Cish+/+ and      
Cish-/- BALB/c mice infected with P. berghei were examined for erythropoiesis, various 
hematological parameters and serum cytokine responses in conjunction with the development 
of parasitemia and anemia. A comparative study was also performed in Cish+/+ and Cish-/- 
C57BL/6 mice to examine how CISH impacts on inflammatory responses and the ability to 
succumb to experimental cerebral malaria (ECM).  
This study revealed in the first instance that the uninfected female BALB/c Cish +/+ and 
Cish -/- mice displayed significant differences in a variety of hematological parameters. The 
Cish-/- mice exhibited a significant increase in the percentage of erythroblasts in the bone 
marrow compared to their wildtype counterparts, most likely in response to the reduced 
erythrocytes, hematocrit and hemoglobin levels in their peripheral blood, and validating the 
role of CISH as a negative regulator of erythropoiesis. The female Cish-/- mice also displayed 
a significant reduction in bone marrow BFU-E (burst forming unit, erythroid) and CFU-Es 
(colony forming unit, erythroid) in keeping with their differentiation into erythroblasts, and 
enhanced granulopoiesis, consistent with a role for STAT5 (signal transducer and activator) in 
this pathway.  
Upon infection with P. berghei, the Cish+/+ female BALB/c mice exhibited reduced 
bone marrow cellularity and a depletion of BFU-E and CFU-E, leading to the production of 
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fewer erythroblasts cells as the infection progressed. The effect on the erythroblast population 
does not appear to stem from parasites infecting these stages as separate studies revealed that 
GFP-fluorescing P. berghei could only infect the more mature orthochromatic stages. The net 
affect was a significant reduction in the number of RBCs in the peripheral blood and 
hemoglobin levels. Infected Cish-/- female BALB/c mice also exhibited reduced bone marrow 
cellularity but in contrast to their wildtype counterparts, the number of BFU-E and Ter119+ 
cells in the bone marrow remained fairly stable throughout the infection despite the fact that 
they were significantly lower than those in Cish+/+ mice prior to infection. Consequently, they 
displayed a significantly slower reduction in peripheral RBC counts and hemoglobin levels, 
which suggests that deletion of Cish does not increase susceptibility to anemia. 
In both genotypes, as the proportion of erythroid cells decreased in the bone marrow, 
the proportion of CD61+, Gr-1+ and CD11b+ cells increased, a potential host response to help 
clear the infection. Inflammatory cytokines that are known to contribute to anemia were also 
elevated in both the Cish+/+ and Cish-/- mice but interestingly some of the chemokines that are 
released by monocytes were significantly increased in female infected Cish-/- mice. Moreover, 
while Cish-/- females displayed significantly low pSTAT5 levels in their erythroblasts relative 
to wildtype prior to infection, the level of pSTAT5 in splenocytes and splenic erythroblasts 
was significantly reduced in both genotypes during infection in spite of extramedullary 
erythropoiesis.  
In relation to the course of parasitemia and outcome of infection no significant 
differences were observed between the BALB/c genotypes. This may be because the infection 
model is an acute model; thus, it remains to be established what the impact of the lower basal 
BFU-E and CFU-E in the bone marrow of the female Cish-/- mice would be in the development 
of anemia in a chronic infection, in which erythropoiesis would be placed under greater stress.  
Among the Cish+/+ and Cish-/- C57BL/6 mice, there were no significant differences in 
the course of parasitemia or their ability to succumb to ECM. However, elevated pro-
inflammatory cytokine and chemokine responses were observed in infected male Cish-/- mice 
in accordance with the findings that depletion of CISH leads to an increase in NK and T cell 
activity. Nevertheless, these responses were not sufficient to have an impact on the outcome of 
the disease, in this model where wildtype mice succumb very rapidly to ECM, making it 
difficult to investigate whether knockout of a gene increases susceptibility to ECM. Taken 
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together, these studies indicate that perturbation of CISH alone is not a major contributor to 
severe malaria disease in an acute infection model.  
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1.1. Malaria: Global impact and major risk groups 
Malaria is a severe febrile illness caused by parasites of the genus Plasmodium.  The parasite 
is spread by the bite of an infected female Anopheles mosquito and thus malaria is prevalent in 
countries with tropical and sub-tropical climates such as Asia, Africa and the Americas where 
the Anopheles mosquitoes thrive. In humans, there are five species of Plasmodium that cause 
malaria, namely Plasmodium falciparum, P. vivax, P. malariae, P. ovale (consists of two 
subspecies P. ovale curtisi and P. ovale wallikeri that differ genetically (Fuehrer and Noedl, 
2014)) and P. knowlesi. The latter is a zoonotic species prevalent in Southeast Asia that causes 
malaria in macaques, but it can also cause severe malarial infection in humans (Singh et al., 
2004). 
Malaria is a global health problem, causing disease on a vast scale. The total burden of 
the disease has been estimated to be 212 million episodes annually, resulting in around 438,000 
deaths each year. Most of these are children under five years of age in Sub-Saharan Africa 
(WHO, 2015). P. falciparum is prevalent worldwide and is the most lethal of the species.  P. 
vivax is found mostly in Asia, Latin America and in some parts of Africa.  This species, along 
with P. ovale, can become dormant in the liver and these so-called ‘hypnozoites’ can be 
activated several months or even years after the infecting mosquito bite to cause disease. This 
relapse is the reason for the high levels of morbidity observed with P. vivax infections.  
Even though malaria is a preventable disease, it is holoendemic in several countries. In 
these regions, malaria causes a high social and economic burden in addition to the burden on 
human health. The major groups at risk are those that have compromised immunity, such as 
children, pregnant women and individuals who are suffering from human immunodeficiency 
virus/ acquired immunodeficiency disorder (HIV/AIDs). In addition, travellers who are not 
native to the endemic regions and are not immune to this disease are more easily prone to 
malaria. 
1.2. Life cycle of Plasmodium  
The life cycle of Plasmodium is complicated and involves two hosts, the mosquito and the 
vertebrate host such as birds, reptiles and mammals. The life cycle of P. falciparum is outlined 
in Figure 1.1. Plasmodium parasites have several distinct lifecycle stages, including the exo-
erythrocytic stages in the liver, the asexual and sexual erythrocytic stages in red blood cells 
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(RBCs) and the sporogenic stages in the mosquito. The exo-erythrocytic cycle commences 
when a mosquito infected with a Plasmodium spp. bites an individual, and sporozoites in the 
salivary glands are injected along with the saliva into the blood stream. Within 30 minutes, the 
sporozoites invade the liver cells, where they grow and multiply. Within 7-10 days, mature 
schizonts are formed, comprising thousands of merozoites. When the schizonts rupture, the 
merozoites are released into the blood stream, where they can invade RBCs to start the 
erythrocytic cycle. During its time inside the RBC, the parasite transforms from a ring stage 
into a trophozoite, the stage at which the parasite is actively digesting hemoglobin and growing. 
The parasite then replicates by a process called schizogony, in which 16-32 individual 
infectious merozoites are formed within a schizont. In P. falciparum, this asexual blood stages 
lasts for ~ 48 hours and is responsible for all the clinical manifestations of the disease. During 
the blood stage, a small population of the parasites differentiate into the sexual forms of the 
parasites, termed gametocytes, which develop over ~ 10 days into male and female 
gametocytes. During the sporogenic cycle, the gametocytes that have been ingested along with 
the blood by a feeding Anopheles mosquito, egress from the encapsulating RBC in the mosquito 
midgut and differentiate into macro (female) and micro (male) gametes. The zygote that forms 
after fertilization transforms into a motile ookinete capable of penetrating the midgut wall to 
develop into an oocyst. During maturation of the oocyst, thousands of sporozoites are formed, 
which ultimately migrate to the salivary gland. Thus, when the mosquito takes another blood 
meal, the parasite can be again transmitted and the life cycle continues.  
1.3. Prophylaxis, treatment and vaccinations for malaria 
It is possible to prevent malaria by avoiding areas where the parasite is prevalent and avoiding 
being bitten by infected mosquitoes through the use of personal protection. Staying inside when 
it is dark, using insecticide-treated bed nets and mosquito repellent sprays all help to decrease 




















Figure 1.1: Life cycle of Plasmodium parasites (www.cdc.gov/malaria)  
This figure extracted from the Centres for Disease Control (CDC) shows the various 
stages of the parasite life cycle, including the exo-erythrocytic (A) and erythrocytic (B) 
stages in the human host and the sporogenic stage (C) in the mosquito vector. The 
infection of the human host begins when a mosquito takes a blood meal, whereas 
transmission of the male and female gametocytes from the blood to the mosquito 
enables the life cycle to be completed in the vector, resulting in the production of 





While anti-malaria drugs like malarone, chloroquine and doxycycline are available to use as 
prophylaxis, this is not practical for people living in malaria endemic countries and some drugs 
cannot be taken by pregnant women. Some of the drugs that are currently used to treat 
Plasmodium infections include primaquine (the only drug active against the dormant 
hypnozoites forms of P. vivax, but which cannot be used in patients with glucose-6-phosphatase 
dehydrogenase deficiency), doxycycline (a form of tetracycline antibiotic which specifically 
results in impaired expression of Plasmodium apicoplast genes) and clindamycin (an antibiotic 
given with chloroquine or quinine that can be used in children and pregnant women, unlike 
doxycycline) (Peatey et al., 2012). At present, artemisinin-based combination therapy (ACT) 
is recommended by the World Health Organization (WHO) for the treatment of P. falciparum 
malaria (WHO, 2006). This is a combination of fast acting artemisinin-based compounds with 
a drug from a different class, such as lumefantrine, mefloquine and amodiaquine, 
sulfadoxine/pyrimethamine, piperaquine and dapsone. 
Resistance to anti-malarial drugs, however, is a recurring problem (Verlinden et al., 
2016). Most commonly, recrudescence of malaria occurs because the patient discontinues 
treatment as soon as the symptoms disappear. Incomplete treatment results in parasites 
persisting in the patient's blood and resistance arises because parasites are exposed to sub-
optimal concentrations of drug. These resistant parasites can be transmitted by a mosquito, thus 
spreading rapidly within a population. Use of counterfeit drugs and improper drug storage that 
results in loss of biological activity also contributes to the generation of drug-resistant parasites. 
An effective immune system that clears the parasites post-treatment plays a crucial part in 
surviving malaria, and thus a failing immune response can also lead to resistance. In some 
circumstances, the drug may be effluxed at a rate that prevents the drug from exerting its mode 
of action. For example, in chloroquine-resistant parasites, the inhibition of heam 
polymerization to hemozoin (Foley and Tilley, 1998) is prevented by the efflux of chloroquine 
(Krogstad et al., 1987). Gene mutations that contribute to drugs resistance, such as in the anti-
folate combination drugs (sulfadoxine and pyrimethamine) have been identified (Plowe et al., 
1998, Triglia et al., 1998, Lundie et al., 2008). Worryingly, parasites are also exhibiting delayed 
clearance to artemesinin in pockets of South East Asia (Dondorp et al., 2009, Noedl et al., 
2010, Bethell et al., 2011). Mutations in the Plasmodium falciparum gene that encodes kelch 
(K13)-propeller domains, which result in reduced ring-stage susceptibility to artemisinins and 
subsequent slow parasite clearance in patients treated with ACTs are now widespread in 
Southeast Asia (Cheeseman et al., 2012, Takala-Harrison et al., 2015). Identifying K13 has 
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provided an opportunity to understand how resistance to artemisinins has arisen and to develop 
control programmes for monitoring the extent of artemisinin resistance (Ménard et al., 2016, 
Fairhurst, 2015). 
While treatment for malaria still has to overcome the burden of resistance in certain 
regions, developing a preventive vaccine that can shield people from being infected in the 
first instance would be ideal. In spite of decades of research, a licensed highly efficacious 
anti-malarial vaccine that prevents both P. falciparum and P. vivax has yet to be rolled out in 
malaria endemic regions. This is largely due to the poor understanding of the biology of 
Plasmodium parasites and their interaction with their host. Moreover, as outlined above, the 
lifecycle is complex and Plasmodium spp. have evolved to escape host immune responses. It 
is important, therefore, to determine what constitutes a proper immunological response 
against Plasmodium spp.  as this knowledge is required for the development of efficacious 
vaccines against malaria. 
When considering the development of a malaria vaccine, distinct life cycle stages of 
the parasite, such as extracellular parasite stages and intracellular liver stages need to be taken 
into consideration as each of these provides a point in which the cycle can be blocked. 
Plasmodium parasites have an estimated 5300 putative proteins expressed at different stages of 
their lifecycle (Gardner et al., 2002), many of which (such as merozoite specific protein 
(MSP1) (Yavo et al., 2016) and apical membrane antigen (AMA1) (Escalante et al., 2001) 
exhibit allelic polymorphisms in different strains of P. falciparum alone. P. falciparum also 
expresses parasite-derived antigens on the surface of parasitized RBCs (pRBCs), known as 
variant surface antigens (VSAs). These parasite-derived proteins include P. falciparum 
erythrocyte membrane protein 1(PfEMP1) (Leech et al., 1984), repetitive interspersed family 
proteins (RIFINS) (Cheng et al., 1998), sub-telomeric variable open reading frame  proteins 
(STEVOR) (Kaviratne et al., 2002) and surface associated interspersed gene family (SURFIN) 
proteins (Winter et al., 2005). Specific variants of PfEMP1 have been linked to disease 
pathogenesis and this could be favourable for vaccine development, but antigenic diversity in 
PfEMP1 is proving to be a major hurdle (Barry and Arnott, 2014). An ideal vaccine should be 
effective against all antigenic or allelic variants to safeguard against variant circulating strains 
in the field (Moorthy and Kieny, 2010). A pre-erythrocytic vaccine would be ideal since it 
would target the development of liver stage when the number of parasites are low. Moreover, 
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it would prevent the blood stage of the lifecycle, thereby preventing both the symptoms and 
further transmission of the infection. 
The vaccine candidate that has progressed the furthest is the RTS,S/ASO1 vaccine. This 
vaccine incorporates the T-cell epitopes from the pre-erythrocytic circumsporozoite 
protein (CSP) of P. falciparum fused to a viral envelope protein of the hepatitis B virus 
(HBsAg), along with a chemical adjuvant (AS01) to enhance the immune system response 
(Agnandji et al., 2012). This vaccine aims at preventing the infection by 
inducing humoral and cellular immunity with high antibody titers, thereby blocking the parasite 
from infecting the liver (Foquet et al., 2014). In 2009, this vaccine underwent Phase III clinical 
trials (The Rts, 2014). In October 2015, WHO advisory groups recommended the pilot 
implementation of RTS,S/ASO1 in some parts of sub-Saharan African (Tinto H et al., 2015). 
In November 2016, WHO announced that the RTS,S vaccine would be started as pilot projects 
in three countries in sub-Saharan Africa, with vaccination programs expected to be initiated in 
2018. 
1.4. Symptoms of malaria 
Malaria causes severe febrile illness in its vertebrate hosts. In humans, the initial symptoms 
include fever, headache, nausea, vomiting and flu-like symptoms such as chills. Malaria 
symptoms appear in a cyclic pattern as the parasites progress through the RBC stages of the 
lifecycle. When the parasites rupture from the RBCs, toxic factors such as hemozoin (Arese 
and Schwarzer, 1997) and glycosylphosphatidylinositol (GPI) (Brattig et al., 2008) lead to the 
stimulation of macrophages. The fever, chills and severities stem from the cytokines and other 
soluble factors that are released from the macrophages (Kern et al., 1989). The time from the 
initial infection until when the symptoms appear (incubation period) generally ranges from 9-
14 days for P. falciparum and varies with each species. If not diagnosed and treated with in the 
first 24 hours, P. falciparum malaria can progress to a severe illness, which has several 
manifestations and can often lead to death. Some of the most common severe manifestations 
are severe anemia, metabolic acidosis leading to respiratory distress and cerebral malaria.  
1.4.1. Cerebral malaria (CM) 
Cerebral malaria (CM) is a severe complication of P. falciparum infection, often 
leading to coma and has a mortality rate of 10–25% (Taylor et al., 2004; Mishra and Newton, 
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2009). CM is most frequent in sub-Saharan Africa and an important cause of mortality and 
morbidity in South East Asia, principally occurring in older children and adults. The 
pathogenesis of CM results from the combination of several factors, including microvascular 
obstruction of pRBC (Pongponratn et al., 2003), pro-inflammatory cytokine responses, 
microvascular thrombosis (van der Heyde et al., 2006, Moxon et al., 2009)  and loss of 
endothelial barrier function (Dorovini-Zis et al., 2011, Beare et al., 2009). 
In order to avoid clearance from spleen, mature forms of blood-stage P. falciparum 
express proteins on the surface of the pRBC such as PfEMP1 (Baruch et al., 1995). This protein 
facilitates binding of the pRBC to particular receptors on endothelial cells and as a result, 
causes sequestration of the pRBC in the vascular beds (Magowan et al., 1988). Such 
sequestration leads to the obstruction of blood flow and subsequent hypoxia and haemorrhages. 
Sequestration is not limited to the brain and can occur for example in the placenta, leading to 
placental malaria (Miller et al., 2002). In addition and as outlined in further detail below, 
inflammatory responses are also a major contributor of CM, with a number of different 
cytokines such as TFN-, IFN- and IL-1 involved (Hunt and Grau, 2003). 
Post mortem reports have been valuable in understanding CM and in a large proportion 
of CM cases, leucocytes and platelets are present within the brain microvasculature (Porta et 
al., 1993, Patnaik et al., 1994). The P. berghei ANKA rodent infection model has been very 
useful in studying experimental CM (ECM) as it exhibits many features in common with 
human CM disease and is the best model available so far (Schofield and Grau, 2005, Hansen, 
2012). For example, in mice susceptible to ECM (like C57BL/6 mice in the case of P. berghei 
ANKA infections), pRBC have been found to accumulate in brains during infection and is 
facilitated by vascular cell adhesion protein 1 (VCAM-1 (El-Assaad et al., 2013).  Also, host 
immune responses contributing to P. falciparum CM or associated with increased risk to 
malaria are also observed in P. berghei ECM. For example, the inflammatory cytokines such 
as TNF- (Grau et al., 1987), IFN-γ (Grau et al., 1989a), IL-1 (Pongponratn et al., 2003), 
LIGHT-lymphotoxin Receptor (LT-R) and the chemokine CXCL10 (Nie et al., 2009) are just 
some of the mediators that contribute to the pathology of ECM. Moreover, during ECM, 
leukocyte populations such as macrophages and neutrophils as well as T cells, NK cells and 
platelets have been found in the blood vessels of brains in P. berghei-infected mice (Belnoue 
et al., 2003, Nitcheu et al., 2003). 
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Several studies have provided evidence that cytokines and immune system effector cells 
contribute to CM in both humans and mice. The role of the pro-inflammatory cytokine TNF- 
in the pathogenesis of ECM has been studied in detail (Clark and Rockett, 1994, Grau et al., 
1989b). TNF- has been shown to be induced by the presence of parasites in the blood 
(Karunaweera et al., 1992, Kwiatkowski et al., 1989)and evidence for its contribution to ECM 
is corroborated by the presence of high serum levels of TNF- at the onset of ECM and the 
prevention of the neurological syndrome upon neutralization of the cytokine (Grau et al., 1987). 
Moreover, transgenic mice expressing high levels of soluble TNF receptor-1 (TNFR1) do not 
develop ECM (Ammann et al., 1997). However, in some studies, high plasma concentrations 
of TNF- have been associated with disease severity but not specifically with CM (Shaffer et 
al., 1991, Molyneux et al., 1991).  
Another pro-inflammatory cytokine, IFN-γ, plays divergent roles in Plasmodium 
infections. It is important in providing anti-malaria immunity, controlling liver and blood-stage 
infection. However, it can also exacerbate the severity of disease depending on the timing of 
its production (King and Lamb, 2015). In P. berghei ANKA infection, administration of an 
IFN-γ-neutralizing antibody gives rise to protection against ECM (Mitchell et al., 2005). 
Moreover, both IFN-γ−/− (Yanez et al., 1996) and IFN-γ receptor (IFN-γR)−/− mice are resistant 
to ECM (Amani et al., 2000) 
Interleukin 1 (IL-1) is another pro-inflammatory cytokine that plays a crucial role 
in the pathogenesis of CM (Clark and Rockett, 1994). Histopathology studies have revealed 
IL-1β in the brain and liver of clinical cases of fatal CM (Udomsangpetch et al., 1997). 
Expression of IL-1 mRNA could also be detected in the spleen, cortex, cerebellum, and brain 
stem of most paediatric patients that died of CM and this expression was absent in uninfected 
individuals (Brown et al., 1999).  
In contrast, anti-inflammatory (Th2-type) cytokines such as IL-10 seem to have a host-
protective role in murine malaria. In a susceptible CBA/J mouse strain, administration of IL-
10 gave some degree of protection against ECM induced by P. berghei ANKA. On the other 
hand, in a resistant BALB/c strain, the neutralization of IL-10 with an antibody led to the 
occurrence of cerebral complications (Kossodo et al., 1997). Addition of IL-10 to peripheral 
blood mononuclear cells inhibits TNF- production (Ho et al., 1998) . There is also evidence 
suggesting that IL-10 inhibits production of several of the chemokines that regulate the 
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trafficking of leukocytes (Moore et al., 2001) and CD8+ T cells in the brain, which may explain 
why it offers protection to some to certain extent. 
Chemoattractant cytokines or chemokines are key regulators of leucocyte trafficking. 
They stimulate the deployment of immune cells to peripheral sites of pathogen challenge and 
inflammation including in Plasmodium infections. Increased levels of various chemokines 
have been observed in the cerebral spinal fluid or brain samples of children with CM, including 
CXCL8 (IL8) (Armah et al., 2007, John et al., 2008b, John et al., 2008a) macrophage 
inflammatory protein-1β (MIP-1β; also known as CCL4) (Sarfo et al., 2004, Armah et al., 2007, 
Jain et al., 2008)  and interferon gamma-induced protein 10 (IP-10; also known as CXCL10) 
(Armah et al., 2007, Jain et al., 2008, Wilson et al., 2011). CXCL8 and CXCL10 have also 
been shown to be predictive of CM mortality (Armah et al., 2007). In P. berghei infected mice, 
microarray analysis revealed that the expression of chemokine receptors CCR5, CXCR3 and 
CCR1 and chemokines, including CXCL9 (also known as monokine-induced by gamma 
interferon (MIG), CXCL10, CCL2 (also known as monocyte chemoattractant protein1; 
MCP1), CCL3 (also known as macrophage inflammatory protein 1-(MIP-1-) and CCL9 
(also known as macrophage inflammatory protein-1 gamma (MIP-1γ) significantly increase in 
response to ECM  (Sexton et al., 2004, Hansen et al., 2005). Gene expression studies in brains 
of ECM-susceptible mice have also shown that CXCL2, CXCL9, CXCL10, CCL2, CCL3, 
CCL4 (also known as macrophage inflammatory protein-1β; MIP-1β), CCL5 (RANTES) and 
CCL7 (also known as monocyte-chemotactic protein 3; MCP3) are upregulated during 
infection with P. berghei ANKA (Campanella et al., 2008, Miu et al., 2008). Of note, the 
expression of CCL2, CCL4, CCL5, CXCL9 and CXCL10 are induced by either IFN-γ or TNF-
, indicating the significance of these pro-inflammatory cytokines in the pathogenesis of ECM. 
Along with the inflammatory cytokine responses, cells such as monocytes, 
macrophages and dendritic cells (DCs) have critical roles in recognizing invasive 
microorganisms and instigating immune responses. Macrophages are phagocytic and also are 
largely a source of pro-inflammatory cytokines. During infection with P. berghei, parenchymal 
macrophages are activated even before leukocyte sequestration in the brain vasculature. They 
undergo morphological changes and over-express MHC class I and Sca-1,  contributing to 
proliferation of CD8+ T cells leading to death of mice (Pais and Chatterjee, 2005). Monocytes 
have been found lining the walls of the blood vessels in CM as well as adjacent to endothelial 
damage, indicating that they could be contributing to vascular damage (Chang-Ling et al., 
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1992, Neill et al., 1993) along with cerebral vascular obstructions (Porta et al., 1993, Patnaik 
et al., 1994). Murine studies show that DCs can also phagocytose blood-stage pRBCs (Ing et 
al., 2006). They also present pRBC-derived antigens to CD4+T cells to initiate the development 
of Th1 dependent immune responses (Ing et al., 2006, Pouniotis et al., 2005). Upon 
encountering microbes, DCs migrate to lymphoid organs, where they change from an 
phagocytic immature stage to a mature stage of efficient T cell stimulation (Banchereau and 
Steinman, 1998), which is complemented by extreme morphological and functional changes. 
Mature DCs express high levels of MHC necessary for efficient T cell stimulation and also 
secrete cytokines and chemokines  (Banchereau and Steinman, 1998). During malaria, DCs are 
activated through Toll-like receptors (TLRs) and are an important source of IL-12, which in 
turn activates NK cells to produce IFNγ (Sedegah et al., 1994) and promotes differentiation of 
Th1 lymphocytes that impart protective immunity against Plasmodium infection (Artavanis-
Tsakonas and Riley, 2002). Thus, whilst monocytes, macrophages and DCs cells are required 
for a productive immune response against the invading parasite, they also contribute to the 
pathogenesis of CM by being a potential source of inflammatory cytokines and chemokines. 
Effector cells such as CD4+ T cells (Yanez et al., 1996), CD8+ T cells (Nitcheu et al., 
2003) and NK cells (Hansen et al., 2007) also contribute to the development of ECM (Grau et 
al., 1987, Grau et al., 1989a). In mice infected with P. berghei ANKA, infiltration of CD8+ T 
cells and monocytes in the brain is mediated by chemokines (Nitcheu et al., 2003, Belnoue et 
al., 2002), leading to damage of the cerebral micro-vascular endothelium (Belnoue et al., 2002). 
IFN-γ-producing CD4+ T cells also help to promote ECM by controlling CD8+ T cell 
accumulation within the brain (Villegas-Mendez et al., 2012). NK cells, which are cytotoxic 
lymphocytes that can affect adaptive immune responses by secreting regulatory cytokines, are 
also found in the brains of mice with ECM. NK complex, the genomic region that controls the 
function of NK cells, determines the pathogenesis of murine cerebral malaria pathogenesis 
during P. berghei ANKA infection. NK cells mediate IFN-γ responses to Plasmodium in both 
human (Artavanis-Tsakonas and Riley, 2002) and mice (Miller et al., 2014). They also 
stimulate the expression of chemokine receptor CXCR3 on Th1-type CD4+ T cells and effector 
CD8+ T cells, which mediate the trafficking of these cells to the brain (Hansen et al., 2007).  
1.4.2 Respiratory distress 
Patients with P. falciparum may also succumb to respiratory distress, of which there 
are varying syndromes such as hyperventilation and acute respiratory distress syndrome 
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(ARDS). Hyperventilation occurs as a result of the increased production of lactic acid by the 
parasite through the direct stimulation of cytokines, leading to metabolic acidosis. The reduced 
blood pH stimulates the brain of the patient to increase the respiratory rate in order to remove 
carbon dioxide. This type of respiratory distress is the main type observed in children in Africa 
but is also frequent in adults (Marsh et al., 1995, English et al., 1996). ARDS concomitant with 
malaria is associated with mortality rates up to 50 % and is marked by alveolar inflammation, 
pulmonary oedema, damage to the alveolar-capillary membrane and severe hypoxemia (Van 
den Steen et al., 2013). The mechanism of pulmonary oedema is not clearly understood but it 
most likely stems from over hydration (Hanson et al., 2013). Sequestration of pRBC leading to 
obstruction of pulmonary microcirculation, intravascular coagulation and increased 
permeability of pulmonary also appears to plays a vital role (Anstey et al., 2007). Volume 
overload and hypoalbuminemia may augment pulmonary capillary leakage. Pulmonary 
oedema is common in patients with hyperparasitemia, and may be the terminal event in many 
cases of fatal falciparum infection (Taylor et al., 2006).  
1.4.3 Severe malaria anemia 
Severe malaria anemia (SMA) is the most common severe disease that arises during a 
Plasmodium infection. Malaria is usually associated with anemia, however, the age of the 
patient, the parasite species and its corresponding drug-resistant profile as well as the nature of 
the innate and acquired immune responses to infection all contribute to determining the severity 
of the anemia. The groups that are at most risk of SMA are children and pregnant women 
infected with P. falciparum (Greenwood, 1997). 
The World Health Organization (WHO) defines SMA as low hemoglobin concentration 
(<5gm/dL) or low hematocrit (<15 %), high parasitemia (>100,000 parasites per micro litres 
of blood) and a normocytic blood film. Apart from these, thrombocytopenia (decreased number 
of platelets in blood), splenomegaly (enlarged spleen) (Bedu-Addo and Bates, 2002), 
hepatomegaly (enlarged liver) and jaundice can also be seen in patients with SMA. Increased 
hemolysis and bone marrow suppression are also seen in infection (Helleberg et al., 2005). The 
anemia of P. falciparum malaria is typified by  low numbers of RBCs, with a pronounced 
absence of reticulocytes (Roberts et al., 2005). 
The pathogenesis of SMA is still relatively undefined, but several factors have been 
implicated. These include extravascular clearance and/or intravascular destruction of pRBCs, 
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clearance of uninfected RBC, activation of the monocyte/macrophage system, suppression of 
erythropoiesis and dyserythropoiesis, the latter of which is defined as morphological and/or 
functional abnormal production of RBCs.  
1.4.3.1. Destruction of pRBCs 
During an infection, pRBCs are destroyed as a result of parasite maturation and 
subsequent rupture of pRBCs to release the merozoite progeny. However, pRBCs are also 
destroyed by macrophages, which recognize the expression of foreign parasite antigens on the 
surface of pRBCs (Patel et al., 2004). Infected RBC may be destroyed by ADCC (antibody 
dependent cell mediated cytotoxicit (Arora et al., 2016), complement dependent killing (Boyle 
et al., 2015) or opsonin independent killing mechanisms (Su et al., 2002). The mononuclear 
phagocyte system in the spleen facilitates the removal of pRBC parasites along with old RBCs, 
leading to the low hematocrit observed in patients with hyperparasitemia (Looareesuwan et al., 
1987).  
1.4.3.2. Hemolysis of uninfected RBCs 
Even though hemolysis of pRBC occurs in infected patients, the lysis of uninfected 
RBCs is the more significant contributor to anemia in malaria (Looareesuwan et al., 1987, 
Dondorp et al., 1997). Several clinical studies suggest that for each pRBC removed or 
destroyed by the mononuclear phagocyte system, at least ten uninfected RBCs are removed 
from the circulation (Evans et al., 2006). During an acute malaria infection, uninfected RBCs 
have reduced deformability, owing to increased oxidation of membrane components 
(Nuchsongsin et al., 2007) and lipid peroxidation of the RBC membrane, leading to their 
recognition by macrophages and thus increased clearance in spleen. (Mohan et al., 1995, 
Dondorp et al., 2003). Deposition of immunoglobulins on the surface of RBCs during 
infections also contribute to the susceptibility of uninfected RBCs to phagocytosis (Waitumbi 
et al., 2000). Moreover, parasite antigens such as rhoptry associated protein 2 (RAP-2/RSP-2) 
(Pouvelle et al., 2000) are deposited on uninfected RBCs, including in the bone marrow (Layez 





1.4.3.3 Alteration to erythropoiesis 
Alteration to the maturation and/or differentiation of RBCs can also lead to SMA. This 
may be due to insufficient erythropoiesis and possibly dyserythropoiesis, in which abnormal 
RBCs are produced in infected patients. Yet to date, we still know relatively little about the 
mechanisms by which the parasite and the host drive altered erythropoiesis in a malaria 
infection. This requires a detailed knowledge of how RBCs develop and mature to understand 
how this may be perturbed in Plasmodium infections and the following Section provides an 
overview of the erythropoietic pathway and its regulation. 
1.5. Erythropoiesis 
 Erythropoiesis is the process in which hematopoietic stem cells (HSCs) undergo 
differentiation and proliferation to generate mature erythrocytes or RBCs. Erythropoiesis is 
triggered by the hormone erythropoietin (EPO) (Gabrilove, 2000, Goodnough et al., 2000), 
which is released in response to hypoxia (decreased O2) in the blood circulation (Palis and 
Segel, 1998). During mammalian development, erythropoiesis occurs successively in the yolk 
sac, the foetal liver and the bone marrow. Around the time of birth, the bone marrow becomes 
the site of erythropoiesis in humans, while in mice the spleen remains as an important 
erythropoietic organ during stress erythropoiesis, even in adult life (Socolovsky, 2007). 
However, under erythroid stress conditions such as low oxygen pressure or anemia, the spleen 
of both mouse and man is used to expand the erythropoietic capacity (Socolovsky, 2007). In 
humans, extramedullary erythropoiesis is less frequent but has been observed in certain disease 
states (Palis and Segel, 1998). 
Within the bone marrow, erythropoiesis occurs in erythroblastic islands, which are 
composed of a central macrophage that extends cytoplasmic protrusions to a ring of 
surrounding differentiation erythroblasts (Chasis and Mohandas, 2008). The macrophages 
provide nutrients as well as proliferative and survival signals to the erythroblasts. In addition, 
the macrophages phagocytose the nuclei extruded by the maturing erythroblasts (Manwani and 
Bieker, 2008). Humans and mouse RBCs under normal physiological conditions have a life 
span of 120 and 40 days, respectively (Piomelli and Seaman, 1993, Horky et al., 1978).  Each 
day, approximately 1 % of human RBCs and 2% of mouse RBC are cleared, meaning a similar 
number needs to be synthesized in order to maintain a normal blood count. Acute or chronic 
stress, trauma or hemolysis can increase this production significantly. In order to warrant a 
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constant production of RBCs, various components are required such as iron for hemoglobin 
synthesis, folic acid and vitamin B12 for DNA synthesis (Koury and Ponka, 2004), along with 
cytokines and steroid hormones (Kolbus et al., 2003). 
Erythropoiesis is initiated by self-renewing hematopoietic stem cells (HSCs) (Fig.1.2). 
These give rise to progeny that gradually lose self-renewal capacity and become restricted to 
one lineage. With respect to the erythroid lineage, the HSC differentiate into the common 
myeloid progenitor (CMP), megakaryocyte erythroid progenitor (MEP), burst forming unit-
erythroid (BFU-E) and then into the rapidly dividing colony forming unit-erythroid (CFU-E). 
The CFU-E undergo three to five mitotic cycles from which erythroblasts are ultimately 
produced. The proerythroblast (Pro) is the first erythroblast stage, which differentiate into 
basophilic (Baso), polychromatic (Poly) and orthochromatic (Ortho) erythroblasts. Finally, 
orthochromatic erythroblasts expel their nuclei and differentiate into reticulocytes. The 
enucleated reticulocytes then expel all their other organelles and are released into the 
circulation where they mature into RBCs.  
As the BFU-E and CFU-E undergo differentiation to produce mature RBCs, they both 
express erythropoietin receptor (EPO-R), specific cell surface markers and transcription factors 
required for this process (Krantz, 1991).  Whilst cells from BFU-e to orthochromatic express 
Epo-R, expression on the more mature stages is significantly reduced and therefore the impact 
of Epo will also be reduced. Glycophorin A is a major sialoglycoprotein of the erythrocyte 
membrane and in mice it is associated with a specific antigen called Ter-119. Ter-119 is 
expressed on early proerythroblasts to mature RBCs but not on erythroid colony-forming cells 
(BFU-E and CFU-E) and thus it is useful for distinguishing erythrocytes and cells in the 
erythroid lineage (Kina et al., 2000). The cell surface marker, Transferrin receptor protein 1 
(TfR1) or Cluster of Differentiation 71 (CD71), serves as a carrier protein to import iron 
transported by transferrin into cells (Aisen, 2004) and is expressed on all stages of erythroid 
differentiation, with the exception of mature RBC (Pan and Johnstone, 1983).  The adhesion 
molecule CD44 exhibits a more progressive decrease in expression from the proerythroblast 
stage to reticulocyte stage when compared to CD71 and, although it is also expressed on other 
cell lineages, it is better able to differentiate Ter119+ cells in the different stages of erythroblast 













Figure 1.2: Erythropoiesis from progenitors to mature cells 
The different stages of erythropoiesis are shown, beginning with hematopoietic stem cell 
(HSC), followed by burst-forming unit erythroid (BFU-E), colony-forming unit erythroid 
(CFU-E), pro-erythroblast (Pro-E), basophylic (Baso-E), polychromatic (Poly-E) and 
orthochromatic erythroblast (Ortho-E), reticulocytes and finally mature erythrocytes. Erythroid 
transcription factors involved in erythropoiesis are indicated: basic helix-loop-helix factor 
(TAL1); zinc finger factors that bind GATA sequences (GATA-1, GATA-2), GATA-1 partner, 
friend of GATA (FOG-1) and erythroid Kruppel-like factor (EKLF). Receptors for 
hematopoietic growth factors, including stem cell factor-receptor/c-kit, erythropoietin receptor 
(EPO-R), Glycophorin A, Ter119, CD71 and CD44 are also shown. 




1.6. Regulation of erythropoiesis 
The production of erythrocytes is a tightly regulated process. Steady state hematopoiesis 
produces approximately 1010 RBCs per hour in the bone marrow in order to maintain the 
hemoglobin levels. RBC production is regulated at many levels, including at the cellular, 
cytokine and transcriptional level. 
1.6.1 Signaling pathways involved in regulation of erythropoiesis 
The kidney is the major site of EPO production, which is produced in response to low 
oxygen levels. EPO is required for definitive erythropoiesis and is the crucial regulator of RBC 
production (Dolznig et al., 2001). Regulation of erythropoiesis is initiated by EPO binding to 
the Epo-receptor (EPO-R) (Youssoufian et al., 1993) and by stem cell factor (SCF) binding to 
the c-kit receptor. However, in the absence of Epo, SCF cannot induce progenitor survival 
(Dolznig et al., 2001). The Epo-R is composed of two identical subunits and upon binding of 
EPO, these subunits dimerize, triggering the downstream activation of multiple intracellular 
signal transduction pathways. This includes the Janus kinase-2 (JAK-2)/signal transducer and 
activator of transcription 5 (STAT5) pathway, the phosphatidylinositol 3-kinase (PI3K)/Akt 
mammalian target of rapamycin (mTOR) pathway and the Shc/Ras/mitogen-activated kinase 
(MAPK) pathway, the first two of which are the most significant contributors to erythropoiesis. 
1.6.1.1 The JAK-STAT pathway 
When EPO is bound to the EPO-R, the JAK-2 tyrosine kinase is recruited to the receptor 
complex (Fig 1.3). JAK-2 phosphorylates eight tyrosine residues on the receptor, which form 
docking sites for transcription factors such as STAT5A and 5B (Smithgall et al., 2000). The 
STAT5 factors are then phosphorylated on a single tyrosine residue by the JAK kinase. STAT3 
and STAT1 are also activated by EPO stimulation but to a lesser extent (Kirito et al., 1997).  
Once phosphorylated, the STAT molecules dimerize and are translocated to the nucleus 
where they act as transcription factors for genes involved in erythropoiesis as outlined further 
in Section 1.6.1.4 (Mulcahy, 2001). The importance of the JAK-STAT pathway in 
erythropoiesis can be evidenced by mutation and knockout studies.  For example, stress 
erythropoiesis is strongly affected by mutation in the Tyr343 required for STAT5 activation 











































Figure 1.3: Regulation of erythropoiesis by various pathways 
Binding of erythropoietin (EPO) to EPO receptors (indicated in black) triggers recruitment of 
JAKs and subsequent phosphorylation of the JAK tyrosine residues, creating docking sites for 
STAT5, PI3K and Ras. Upon translocation of these factors to the nucleus, they carry out the 
EPO-induced gene expression required for erythropoiesis. Negative feedback is carried out by 
phosphatases like SHP-1 and SOCS-1 and 3 as well as CISH, which block the docking sites 




In Stat5a-/-/b-/- mice, erythroid progenitors are present in low numbers and are less 
responsive to EPO. The progenitors also show erythroid differentiation instead of renewal, 
leading to accumulation of mature cells along with gradual proliferation arrest. One of the 
promoters that STAT5 binds to is that of the Bcl-X gene (Dolznig et al., 2006). Stat5a-/-/b-/- 
mice also show higher levels of apoptosis because they lack the ability to induce the anti-
apoptotic protein Bcl-X1 (Socolovsky et al., 1999). Combined, these studies indicate the 
importance of STAT5 in sustaining a high erythropoietic rate. Similarly, JAK2 -/- embryos die 
from acute anemia during 11 to 13 days of embryogenesis (Neubauer et al., 1998, Parganas et 
al., 1998) as erythroid maturation is affected. JAK2 is not only involved in EPO-R signaling; 
it also is involved in signaling through several other cytokine receptors that are essential for 
proliferation and survival of primitive erythroid progenitors (Neubauer et al., 1998, Parganas 
et al., 1998). 
1.6.1.2 The PI3K/Akt/mTOR pathway 
Binding of EPO to the EPO-R and stem cell factor (SCF) to c-kit (which is highly 
expressed on both HSCs and progenitor cells) also triggers activation of the PI3K/Akt/mTOR 
pathway (Fig. 1.3). P13K comprises p85 (regulatory subunit)/p110 (catalytic subunit), of which 
p85 is directly recruited to EPO-R phosphorylated tyrosine residues (Constantinescu et al., 
1999).  Activation of PI3K upregulates cyclins D3, E, A and c-Kit, thereby influencing the 
progression of the cell (Sivertsen et al., 2006). The serine/threonine kinase, Akt, is activated 
downstream of PI3K through 3’-phosphorylated inositol lipids (PIP3) (von Lindern et al., 
2000) and activates or deactivates its substrates via its kinase activity. Many downstream 
substrates of Akt play an important role in regulating proliferation and survival of erythroid 
progenitors (Somervaille et al., 2001).  
1.6.1.3 The Shc/Ras/mitogen-activated kinase (MAPK) pathway 
 EPO also activates the Ras pathway through several mechanisms (Fig 1.3). Growth factor 
receptor-bound protein 2 (Grb2), a cytoplasmic adapter protein, can bind directly through its 
SH2 domain to the tyrosine phosphorylated EPO-R, or indirectly through the tyrosine 
phosphatase SHP2, which lead to activation of Ras. Ras activation is essential for the 
differentiation, proliferation, and survival of erythroid progenitors in vitro. In mammals, Ras 
is particularly required for the differentiation of erythroid progenitor cells to late basophilic 
erythroblasts and for the proliferation of hematopoietic progenitors (Khalaf et al., 2005). 
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1.6.2 Negative regulation of erythropoiesis 
In order to maintain the number of RBCs in a steady state, a negative feedback loop is 
clearly required at various levels, failing of which might lead to overproduction of erythroid 
cells, subsequent hyper viscosity and increasing the risk of thrombosis. Various phosphatases 
such as the Src homology 2 domain tyrosine phosphatases (SHP-1 and SHP-2) and SH2 
domain-containing inositol 5'-phosphatase (SHIP) interact with phosphorylated c-Kit 
(Linnekin et al., 1997, Serve et al., 1994). This leads to the dephosphorylation of the EPO-R, 
resulting in inactivation of all pathways downstream of c-Kit signaling. Moreover, SHP-2 
interacts with c-Kit at a tyrosine residue to influence the activation of the MAP kinase pathway 
(Munugalavadla and Kapur, 2005). 
Apart from phosphatases, the suppressor of cytokine signaling (SOCS) family of 
proteins are also involved in the control of EPO-R activation (Sasaki et al., 2000). SOCS genes 
are activated in response to a variety of cytokines and, through a negative feedback loop, 
suppress cytokine-induced signal transduction. Three SOCS genes, those being SOCS-1, 
SOCS3 and the cytokine inducible SH2 containing protein CISH, are associated with 
erythropoiesis. SOCS-1 binds to JAK2 and inhibits its activation. SOCS-3 is tyrosine 
phosphorylated in response to EPO stimulation and suppresses EPO signaling by associating 
with the EPO-R and JAK2. The activation of JAK2 and STAT5 also results in the expression 
of CISH. The promoter region of CISH gene contains four STAT5 binding sites, which are 
required for its EPO-dependent activation (Matsumoto et al., 1997). Recruitment of CISH to 
the EPO-R via the SH2 domain results in suppression of proliferation. Mice lacking both Stat5a 
and Stat5b have no CISH expression in their ovaries (Teglund et al., 1998, Mui et al., 1996). 
Hence, CISH could be regulating EPO signaling by concealing the STAT5 binding site on the 
EPO-R. However, mice lacking the CISH gene appear phenotypically normal with respect to 
the phenotypes that have been analysed, possibly as a result of functional compensation by 
other SOCS proteins (Marine et al., 1999). 
1.6.3 Erythropoiesis at the transcriptional level 
During erythroid differentiation, erythroid-specific genes are expressed in a precisely-
timed manner. Moreover, the erythroblasts need protection from apoptosis. These processes 
are mainly regulated at the transcriptional level. GATA-1 and GATA-2 are nuclear zinc finger 
proteins that belong to a family of transcription factors and are considered to be the most critical 
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transcription factors in the regulation of erythropoiesis as well as in megakaryopoiesis. 
(Ikonomi et al., 2000, Ohneda and Yamamoto, 2002). Testimony to this, ablation of GATA-1 
in mice causes arrest of erythroid maturation and severe anemia leading to embryonic death 
(Gutierrez et al., 2008) and chimeric mice harbouring an embryonic stem cell line with a 
mutation in the Gata1 show arrested erythroid differentiation (Pevny et al., 1991). 
Both GATA-1 and GATA-2 require interaction with a cofactor called friend of GATA 
(FOG)-1 (Chang et al., 2002, Tsang et al., 1998). Along with FOG1, GATA-1 activity is also 
dependent on interaction with many other cofactors such as EKLF, SP1, CBP/p300, Lmo2, 
Ldb1, RUNX1, Fli1 and PU.1, which constitute a very complex network regulating 
erythropoiesis and megakaryopoiesis (Shivdasani, 2001, Morceau et al., 2004). For example, 
PU.1 is a strong inhibitor of GATA-1 DNA-binding activity and erythroid differentiation 
(Rekhtman et al., 1999, Stopka et al., 2005). Tal-1 is another transcription factor involved in 
erythropoiesis and is phosphorylated in response to EPO stimulation (Prasad et al., 1995) by 
PI3K-activated MAPK signaling pathway (Tang et al., 1999). 
During erythroid differentiation, erythroid progenitors constitutively express pro-
apoptotic proteins of the Bcl-2 family, including Bcl-xL, which serve to protect erythroid 
progenitors from apoptosis (Rhodes et al., 2005). However, erythroid cells are not entirely 
protected from apoptosis, and the rate of apoptosis appears to be determined by levels of EPO 
and Fas-L (Fas ligand). The Fas ligand is a transmembrane protein that belongs to the TNF family 
(Janssen et al., 2003), and the binding of this to its receptor induces apoptosis (Nagata, 1994). 
Caspase-3, which belongs to a family of proteases involved in cell death and inflammation, is 
involved in degradation of the transcription factors that regulate bcl-XL gene expression such 
as SCL/TAL-1 and GATA-1 (Zeuner et al., 2003, De Maria et al., 1999).  
1.7 Contribution of Plasmodium to perturbed erythropoiesis 
As outlined in Section 1.4.3.1 and 1.4.3.2, patients infected with P. falciparum and P. vivax 
exhibit anemia as a consequence of destruction of pRBC and haemolysis of uninfected RBC. 
In addition, RBC production is perturbed, stemming from insufficient erythropoiesis or 
dyserythropoiesis, in which erythroblasts show cytoplasmic vacuolization, fragmentation, 
intercytoplasmic bridges and multi-nuclearity (Wickramasinghe and Abdalla, 2000). These 
perturbations lead to reduced reticulocyte production, which is a functional indicator of 
disruption of erythropoiesis in the bone marrow (Abdalla et al., 1980, Abdalla, 1990). In 
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clinical studies, histologic examination of the bone marrow of children who have died from 
malaria reveal that pigmented erythroid and myeloid precursors are associated with the degree 
of abnormal erythroid development (Casals-Pascual et al., 2006).  In the case of insufficient 
erythropoiesis, the numbers of BFU-E and CFU-E are insufficient to generate appropriate 
numbers of RBCs. As EPO has been found to be elevated in the serum of African children with 
severe malaria-related anemia (Burchard et al., 1995, Vedovato et al., 1999), deficiency of EPO 
does not appear to be a major contributor to inadequate erythropoiesis in malaria (Chang and 
Stevenson, 2004). On the other hand, reduced iron levels and circulating factors (both host and 
parasite-derived) appear to inhibit erythropoiesis (Abdalla et al., 1980, Pathak and Ghosh, 
2016) by mechanisms outlined further below.  
1.7.1. Altered iron metabolism  
As iron is required for the production of RBCs, altered iron metabolism can contribute 
to the perturbation of erythropoiesis. (Phillips et al., 1986). The peptide hormone hepcidin 
produced by the liver is the master regulator of iron levels in the body. Hepcidin has been 
implicated in mediating SMA by reducing the availability of iron stores required for 
erythropoiesis (Frazer et al., 2002).  Hepcidin is regulated by pro-inflammatory mediators such 
as TNF- and interleukin- 6 (IL-6), which are elevated in both murine infections and in patients 
presenting with severe falciparum malaria (Abdalla et al., 1980, Lyke et al., 2004). Studies in 
murine malaria suggest that elevated hepcidin results in low serum iron, decreased iron 
availability for erythropoiesis and progression to severe disease (Wang et al., 2011a, Casals-
Pascual et al., 2012). Interestingly, routine iron supplementation along with folic acid in 
children in areas with high rates of malaria, resulted in increases in the incidence of malaria  or 
death (Sazawal et al., 2006)  but the mechanisms by which additional iron can benefit the 
parasite are still not clear (Prentice et al., 2007). 
1.7.2 Suppression of erythropoiesis by parasite products 
Hemozoin and glycosylphosphatidylinositols (GPIs) attached to parasite antigens may 
also affect erythropoiesis.  Hemozoin is formed when hemoglobin is digested by the 
Plasmodium parasite (Pagola et al., 2000) and it is phagocytosed by monocytes/macrophages 
and neutrophils. During acute malaria, accumulation of phagocytes containing malarial 
pigment is seen in the bone marrow (Perkins et al., 2011). Clinical studies indicate that there is 
association between monocytes containing hemozoin and suppression of erythropoiesis in 
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children with P. falciparum infection (Casals-Pascual et al., 2006, Awandare et al., 2006). Co-
cultivation of human monocytes that contain hemozoin with human erythroid cells revealed 
that hemozoin affected erythroid development by hampering cell cycle progression of the 
erythroid precursors and reducing GATA-1 transcription (Skorokhod et al., 2010). Similarly, 
free heme may affect deformity of infected RBCs, leading to their clearance in malaria along 
with the pRBCs (Nuchsongsin et al., 2007). In another study, mice infected with Plasmodium 
chabaudi that had been pre-treated with hemin exhibited reduced parasitemia but displayed 
aggravated anemia, indicating the complex role played by heme products in malaria (Dalko et 
al., 2013). 
1.7.3. Suppression of erythropoiesis by cytokine responses during an infection 
Cytokines are involved in the growth and differentiation of several immune and 
hematopoietic cells, including in the maturation of erythroid of cells (Chasis and Mohandas, 
2008). TNF-, for example, which plays a critical role in arrest of parasite replication and 
parasite killing (Clark et al., 1990) can also inhibit all stages of erythropoiesis. A number of 
polymorphisms in the human TNF- promoter are also associated with anemia (Kurtzhals et 
al., 1998, Pagola et al., 2000, Skorokhod et al., 2010). Mice infected with P. chabaudi display 
suppressed erythroid colony formation, erythroid differentiation and hemoglobin formation 
(Martiney et al., 2000). Hemozoin is known to mediate the release of TNF- from macrophages 
(Sherry et al., 1995). Hemozoin has also been shown to induce the expression of TNF- in 
erythroid cultures (Lamikanra et al., 2015). 
IFN- is produced by NK cells and regulatory T cells during the early phase of the 
immune response to a malarial infection and is crucial in the protection against infection during 
childhood. IFN- is associated with higher hemoglobin levels and reduced prevalence of severe 
malaria anemia in Kenyan children (Ong'echa et al., 2003). However, over production of IFN-
 is associated with anemia and along with nitric oxide and TNF- can aggravate anemia by 
causing bone marrow suppression, dyserythropoiesis and erythrophagocytosis (Lyke et al., 
2004). IFN- inhibits erythroid growth and differentiation by upregulating expression of TNF-
related apoptosis-inducing ligand (TRAIL) and TNF--like weak inducer of apoptosis 




1.8. Variation in CISH expression is associated with susceptibility to infectious diseases 
From the above examples, it is clear that whilst cytokines play critical roles in parasite 
clearance, excessive cytokine-mediated inflammatory responses can be detrimental to the host 
and can lead to increased susceptibility to malaria (Khor et al., 2007). A further case in point 
is that of CISH; increased CISH activity blocks STAT5 activation and in turn, inhibits signaling 
through receptors such as the EPO-R and IL-2R and downstream transcriptional responses. 
However, single nucleotide polymorphisms at positions -639, -292, -163, +1320 and +3415, 
relative to the CISH gene have been found to be associated with susceptibility to bacterial and 
tuberculosis infections as well as severe malaria disease, although whether there was 
association with a particular disease outcome (CM, respiratory distress or severe malaria 
anemia) was not defined (Khor et al., 2010). Decreased CISH expression and a subsequent 
subdued response to stimulation of IL-2 was seen in adult subjects carrying the -292 variants. 
The overall risk of severe malaria disease, septicaemia and tuberculosis was increased by at 
least 18% in persons carrying the variant CISH alleles (Khor et al., 2010). Thus, variants of 
CISH are associated with vulnerability to infections, suggesting that negative regulators of 
cytokine signaling are crucial in determining the immune responses of the host. 
1.9. Role of CISH in regulating signaling through receptors other than EPO-R 
Not only can CISH be induced by EPO (Yoshimura et al., 1995), it can also be induced by 
cytokines such as IL-2 (interleukin-2), IL-3 (interleukin-3) and GM-CSF (granulocyte 
macrophage colony stimulating factor). More recently, CISH has been shown to be a negative 
regulator of IL-15 signaling in NK cells.  Upon deletion of Cish in mice, NK cells became 
hypersensitive to IL-15 and as a result, showed enhanced proliferation, survival, IFN-γ 
production and cytotoxicity toward tumours (Delconte et al., 2016). CISH negative regulation 
of STAT5 also results in shutting down the proliferation of dendritic cells (DC) progenitors, 
facilitating the differentiation of DCs into potent stimulators of cytotoxic CD8+ T lymphocytes  
(Miah and Bae, 2013). CISH has also been shown to silence TCR signaling in CD8+ T cells, 
enhancing their expansion, functional avidity, and cytokine polyfunctionality (Palmer et al., 
2015). In contrast, CISH positively regulates CD4+ T cell proliferation (Li and Langhorne, 
2000). Taken together, CISH appears to play a pivotal role in cytokine signalling and immunity, 
but the mechanism by which CISH increases susceptibility to infections, including severe 
malaria disease remains unknown. 
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1.10 Thesis hypotheses and aims  
The mechanisms by which anemia occurs during a Plasmodium infection still remain poorly 
defined. Mouse models have provided a useful resource to study malaria anemia but few studies 
have examined the bone marrow erythropoietic and hematopoietic responses during a 
Plasmodium infection. Whilst polymorphisms in CISH are associated with susceptibility to 
severe disease, it is unknown whether CISH polymorphisms contribute to SMA or indeed if 
they play a role outside of erythropoiesis and, for example, contribute to other severe outcomes 
such as cerebral malaria.  
The hypotheses that will be tested in this thesis are that mice infected with P. berghei 
exhibit perturbed erythropoiesis in the bone marrow and that CISH increases susceptibility to 
both severe malaria anemia and cerebral malaria through its negative regulatory activity on 
diverse receptors involved in cytokine signaling. Thus, the objectives of this study are: 
AIM 1: To investigate changes in the hematopoietic and erythrocytic responses in the bone 
marrow of P. berghei infected mice. 
AIM 2:  To investigate if Cish-/- mice develop severe malaria anemia in response to a P. berghei 
infection. 
AIM 3: To investigate if Cish-/- mice infected with P. berghei are more susceptible than their 
wildtype counterparts to succumbing to experimental cerebral malaria.


























Equipment and reagents for these studies were supplied from the following list of 
manufacturers: 
 Amresco, Solon, OH, USA  
 Astral Scientific, Sydney, NSW, Australia 
 Becton Dickinson, Franklin Lakes, NJ, USA 
 BOC, Sydney, NSW, Australia 
 Corning, NY, USA 
 eBioscience, San Diego, CA, USA 
 Fisher Biotech, Wembley, WA, Australia 
 Fluka Biochemika, Buchs, Switzerland 
 Grale HD Scientific, Melbourne, Victoria, Australia 
 Hospira, Mebourne, VIC, Australia 
 Hemocue, Angelholm, Sweden 
 Interpath, Melbourne, Victoria, Australia 
 Invitrogen, Carlsbad, CA, USA 
 Jansenn, High Wycombe, UK 
 John Morris Scientific, Chatswood, NSW, Australia 
 Life Technologies, Carlsbad, CA, USA 
 Lonza, Basel, Switzerland 
 Merck Millipore, CA, USA 
 Millipore, Billerica, MA, USA 
 Miltenyi Biotec, Cologne, Germany 
 New England Biolabs, Ipswich, MA, USA   
 Pacific Laboratory Products, Blackburn, VIC, Australia 
 Proscitech, Kirwan, QLD, Australia 
 Provet, VIC, Australia 
 Qiagen, Melbourne, Australia   
 Roche Molecular Biochemicals, Indianapolis, IN, USA   
 R&D systems, Minniapolis, MN, USA 
 Sarstedt, Nümbrecht, Germany 
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 SCIL animal care company, Gurnee, IL, USA 
 Sigma‐Aldrich, Sydney, NSW, Australia   
 Tree Star, Ashland, Oregon, USA 
 Thermo Fisher Scientific, Waltham, MA, USA   
 Vector Laboratories, Burlingame, CA, USA 
 VWR, Tingalpa, QLD, Australia 
 2.2 Mice and ethics approval 
In this study, female BALB/c mice of 6-8 weeks of age were used as donor mice to 
establish a Plasmodium berghei infection from liquid nitrogen stabilities and for all 
anemia studies. For studies assessing the contribution of CISH in susceptibility to 
malaria infection and severity of disease, homozygous cish knockout mice (cish-/-) were 
used. These mice were generated in C57/Bl6 mice by the Australian Phenomics 
Network at Monash University through the insertion of a LacZ cassette between the 
promoter region and exon one of the cish gene on chromosome nine to prevent the 
translation of the CISH protein. The generation of inbred C57/Bl6 and BALB/c cish-/- 
lines was performed by Saeed Maymand at Deakin University (PhD thesis under 
preparation).  The cish-/- on a BALB/c background were used for the anemia studies, 
whilst cish-/- on a C57/Bl6 background were used for experimental cerebral malaria 
studies.  Both male and female Cish-/- mice of between 6-8 weeks of age were used, 
with their Cish+/+ littermates serving as the control.  
Mice were housed under controlled 210C temperature with a 12:12 hour light 
dark cycle. All experiments involving the use of animals were performed in strict 
accordance with the recommendations of the Australian Government and the National 
Health and Medical Research Council Australian code of practice for the care and use 
of animals for scientific purposes. The protocols were approved by the Deakin 
University Animal Welfare Committee (approval number G37/2013 and G37/2012).  
2.3 Parasite lines 
The parasite lines used in this project were wildtype P. berghei ANKA and P. berghei 
EXP2-2A-FRT. The latter is a transgenic parasite line that has been modified at the 
EXP2 (exported protein 2) locus such that EXP2 is fused to a 2A self-cleavage peptide 
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and mCherry (mCh) reporter. This line also expresses an exported GFP reporter 
(KAHRPL-GFP) in which the sequence of KAHRP (Plasmodium falciparum knob-
associated histidine-rich protein) that directs export into the host RBC is fused in frame 
to GFP and placed under the transcriptional control of the HSP70 promoter (HSP70 5′) 
(Kalanon et al., 2016) 
2.4 Infection of mice with P. berghei 
Stabilites of mouse RBCs infected with P. berghei ANKA were stored in liquid 
nitrogen. For infection of a BALB/c donor mouse, 200 L of thawed parasitized blood 
was injected into the peritoneal cavity of the mouse. Once the donor mouse reached 5-
10% parasitemia, it was humanely killed using slow filling CO2 and bled by cardiac 
puncture. Parasitized blood was diluted with PBS (1.3M NaCl, 27mM KCl, 100mM, 
Na2HPO4, 18mM K2HPO4) and the required dose of parasitized RBCs (pRBCs) 
(between 104-106) then injected into the intraperitoneal cavity of experimental mice. 
Mice were monitored daily and parasitemias were assessed daily from day 3 post 
infection by tail blood smears. For this, thin smears of tail blood were fixed in 100 % 
(v/v) methanol for one minute and stained with a 10 % (v/v) Giemsa solution (Merck 
Millipore) for 10 minutes. The parasitemia was calculated by counting a minimum of 
1000 erythrocytes by light microscopy at 100 x magnification under oil. 
2.5 Clinical examination of infected mice  
Mice were scored for their ability to succumb to experimental cerebral malaria (ECM) 
by examining symptoms such as ataxia, convulsions, limb paralysis and inability to 
self-right. When the mouse displayed at least three of these symptoms they were 
deemed to have ECM. Mice were humanely culled using slow filling CO2 when they 
succumbed to ECM or when the parasitemia of the mouse reached > 25 %. 
 2.6 Mouse blood analysis 
Hemoglobin levels in the blood were determined using a HemocueTM HB201 
instrument using a drop of tail blood from the mouse. Alternatively, 20 µL of mouse 
blood was collected using minivettes (SarstedtTM) and the blood was analysed using a 
haematology analyser according to the manufacturer's instructions (SCIL). 
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Haematology parameters of mouse blood such as hemoglobin, white blood cell (WBC) 
count, red blood cell (RBC) count, platelet count, hematocrit, mean cell volume (MCV), 
mean corpuscular hemoglobin concentration (MCHC), mean corpuscular hemoglobin 
(MCH) were analysed with this device. 
2.7 Harvesting of mouse bone marrow and spleen cells  
The bone marrow cells were extracted from both the femurs and tibia of uninfected and 
P. berghei-infected mice by flushing out the marrow with 1 mL of RPMI 1640 media 
(Life Technologies) using a 26-gauge needle. Spleen cells were isolated from the spleen 
by mashing the spleen with the plunger of a 1 mL syringe with 5 mL RPMI 1640 media. 
A single cell suspension was achieved by filtering the cells through a 40 µM nylon 
mesh cell strainer (Interpath). The cells were centrifuged at 1000 x g and the pellet was 
resuspended in PBS buffer containing 1 % (w/v) bovine serum albumin (BSA).  
2.8 Antibodies and stains 
The following antibodies and stains used throughout this study for flow cytometric 
analysis or fluorescence microscopy were purchased from BD biosciences. Antibodies 
included CD16/CD32 (Fcγ III/II Receptor), PE-conjugated anti-Ter119, APC-
conjugated anti-CD44 (clone IM7), APC-Cy 7–conjugated anti-CD45 (clone 30-F11), 
APC-Cy 7–conjugated anti-CD11b (M1/70), FITC–conjugated anti-GR-1(clone RB6-
8C5), AF488-conjugated anti phospho STAT5 (pY694), AF488-conjugated isotype 
control Mouse IgG1, κ, and BD-viability stain 450 (VS-450). 
2.9 Fluorescence microscopy 
Erythroblasts parasitized with GFP-expressing parasites were labelled with PE-
conjugated anti-mouse Ter119 and the nuclear stain 4',6-diamidino-2-phenylindole 
(DAPI, 0.5µg/mL) (Vector Labs). Images were taken on an Olympus IX71 microscope 
and images were processed using ImageJ version 1.47d (http://rsbweb.nih.gov/ij/) or 





2.10 Antibody staining for flow cytometric analysis 
Bone marrow or spleen cells were suspended in 1 % (w/v) BSA buffer made in PBS at 
the concentration of 1x106 cells/50 μL and incubated with rat anti–mouse CD16/CD32 
(2.5 μg/106 cells) for 15 minutes on ice. Samples were subsequently stained with PE-
conjugated rat anti–mouse TER-119 (0.5 μg/106 cells), APC-conjugated rat anti–mouse 
CD44 (0.2 μg/106 cells), APC-Cy 7–conjugated anti-CD45 (0.1 μg/106 cells), APC-Cy 
7–conjugated anti-CD11b (0.1 μg/106 cells), and FITC conjugated anti-GR-1(0.1 
μg/106 cells) on ice for 20 to 30 minutes in the dark. Cells were spun down at a speed 
of 1000 x g and resuspended in 1000 μL PBS containing 1% (w/v) BSA. This step was 
repeated in order to wash the cells. Cells were suspended in 0.2 mL of PBS containing 
1% (w/v) BSA and analysed within 1 hour of staining on a BD FACS CANTO II 
analyser (Becton Dickinson). Unstained cells were used as a negative control and 
single-stained cells were used to determine where the gates were set.  
2.11 Immunofluorescent staining of intracellular phospho-STAT5  
Bone marrow or spleen cells were first spun down at 1000 x g at 40C and resuspended 
in 1 mL of phosphowash buffer (1 x PBS, 1 mM sodium orthovanadate, 1 mM β-
glycerol phosphate and 100mM sodium fluoride (Sigma). To this buffer, PE-conjugated 
Ter119 and APC-conjugated CD44 was added and surface staining of cells was allowed 
to proceed by incubation for 30 minutes on ice. During the last 10 minutes of this 
incubation, live dead discrimination viability stain VS-450 was added at a concentration 
of 2 L/1x106 cells. Following this, the cells were spun down and resuspended in fixing 
buffer (2% (v/v) paraformaldehyde and 0.0075% (v/v) glutaraldehyde in PBS/3 %(w/v) 
BSA) for 10 minutes at room temperature (RT). The fixatives were subsequently 
quenched by addition of phosphowash buffer containing 500 mM Tris and incubation 
for 10 minutes at RT. Following this, the cells were washed with phosphowash buffer 
and then permeabilized by incubation in phosphowash buffer containing 0.2% (v/v) 
Triton-X for 10 minutes at RT.  The cells were again washed with phosphowash buffer 
and resuspended in 100 µL of phosphowash buffer containing either anti-mouse 
phospho-STAT5 antibody or the isotype control mouse IgG1, κ (20 L/1x106 cells) and 
incubated for 30 minutes on ice. The cells were then washed twice and resuspended in 
200 µL of phosphowash buffer and analysed by flow cytometry.  
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2.12 MACS separation of cells using antibody-coated magnetic beads 
A single cell suspension of 1x107 mouse bone marrow or spleen cells was resuspended 
in 90 µL of MACS buffer (PBS containing 0.5 % (w/v) BSA and 2 mM EDTA). To 
this, 10 µL of Ter119 magnetic beads (Miltenyi) were added to the cells and incubated 
at 40C for 15 minutes.  Meanwhile, the magnetic column was prepared by placing the 
MS column (Miltenyi) on the magnetic separator and passing 3 x 500 µL of MACS 
buffer through the column. The effluent that was collected represents the unlabelled 
fraction. To collect the labelled Ter119+ cells, the column was then removed from the 
magnetic separator and the bound cells were flushed out using 1mL of the MACS 
buffer. The cells were then labelled with the appropriate antibody prior to analysis by 
flow cytometry and fluorescence microscopy.  
2.13 Flow cytometry and cell sorting 
A minimum of 10,000 and up to 10,000,000 stained cells were analysed by flow 
cytometry with a BD FACS CANTO II flow cytometer (BD Biosciences). This analyser 
was equipped with blue (488nm, 20mW), red (633nm, 17mW) and violet (405nm, 
30mW) lasers. In circumstances where cells had to be sorted, a BD FACS Aria II cell 
sorter, equipped with violet (405nm, 50mW), blue (488 nm, 20mW) and red (633 nm, 
18mW) lasers was used. Events were collected with FACS Diva software or BD FACS 
software. Cell debris and noise were removed from gating analysis based on FSC/SSC 
properties. Single cells were gated based on the FSC area to height ratio. Compensation 
and further analysis was performed using FlowJo v.10.0.6 (Tree Star). 
2.14 Methyl cellulose colony assay for mouse hematopoietic progenitor cells 
Bone marrow cells were harvested aseptically from femurs and tibias of mice using 
Iscove's modified Dulbecco's medium (IMDM) (Sigma) containing 2 % (v/v) FBS and 
resuspended to a final concentration of 5 x 105 cells/100 µL IMDM. To this cell 
suspension was added 1mL of thawed methyl cellulose (R&D systems). The cells and 
medium were then mixed by vortexing and spread onto a 5 mL cell culture dish prior 
to incubation at 37°C with 5% CO2. The colonies were observed using an inverted 
microscope (40x magnification) and identified as either CFU-GEMM (Colony forming 
unit-granulocyte, macrophage), CFU-GM (colony forming unit-granulocyte, 
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macrophage), CFU-G (colony forming unit-granulocyte) CFU-M (colony forming unit-
macrophage), CFU-E (colony forming unit, erythroid) or BFU-E (burst forming unit, 
erythroid) based on their morphology. The colonies were counted on days 4 for CFU-
Es and day 8 for BFU-Es, CFU-GEMM, CFU-GM, CFU-G and CFU-Ms after plating. 
2.15 Serum cytokine analysis 
Mouse serum cytokine levels were measured using the ProcartaPlex Mouse Cytokine 
and Chemokine Panel 1 kit (26 plex, eBioscience) according to manufacturer’s 
instructions. The cytokines and chemokines analysed are IL-12, IL-23, IL-27, CCL2 
(MCP-1), CCL5 (RANTES), CCL7 (MCP-3), CXCL1 (GRO),CXCL10 (IP-10), 
Eotaxin, GM-CSF, IFN-, IL-1, IL-10, IL-13, IL-17A, IL-18, IL-2, IL-22, IL-4, IL-
5, IL-6, IL-9, MIP-1, MIP-1, TNF-, MIP-2. 
2.16 Statistical analysis 
Statistical analysis was performed using Graph Pad prism vs 6. GraphPad Software, La 
Jolla California USA (www.graphpad.com). For time to event data analysis, (survival 
curves), a Wilcoxon rank test was used to determine statistical significance, whereas 
for parasitemia and body weight analysis a two-sided t-test was performed. For all other 
experiments, either a one-way Anova test or an unpaired t-test was used. A p value 
<0.05 were considered significant.








Analysis of erythropoietic responses in 





Although one of the most common causes of mortality arising from infection with P. 
falciparum is severe malaria anemia (SMA), little is known about the effect 
Plasmodium parasites have on erythropoiesis. Therefore, the aim of this chapter was to 
elucidate the mechanism(s) by which infection with Plasmodium parasites influences 
erythropoiesis. In this case, the rodent malaria species P. berghei was used as animal 
models are available for this species.  The erythrocytic response in mice infected with 
P. berghei was investigated by analysis of bone marrow and spleen cells and 
determining the changes that occur to cells in the erythroid and other hematopoietic 
lineages during the course of the infection. Since pSTAT5 is involved in the activation 
of transcription of genes involved in erythropoiesis, pSTAT5 levels were also measured 
during the infection. 
3.2 Results 
In order to investigate whether perturbations in the erythropoietic response in mice 
infected with P. berghei contributed to malaria induced anaemia, an acute infection 
time course was designed. Groups of six female BALB/c mice of ~ 6-8 weeks of age 
were infected with 1×106 P. berghei-parasitised RBCs (pRBCs) on either day 0, 1, 3 
or 5 in order to establish an infection time course and compare uninfected mice with 
infected mice at days 3, 5, 7 and 8 post infection. Parasitemias were determined daily 
by counting Giemsa-stained blood smears. On the eighth day, all mice were humanely 
killed and the bone marrow and spleen cells harvested for further analysis. The time 
course experiment was repeated a total of six times and the data collected. 
3.2.1 Parasitemia and cellularity of bone marrow and spleen during 
infection  
As expected, the parasitemia of the mice varied according to the number of days 
post infection (d.p.i), with maximal parasitemia in mice infected for 8 days reaching a 
mean of 14.3 %± 1.6 % (Fig. 3.1. A). Spleen cells and bone marrow from the femur 
and tibia of each infected mouse as well as from an uninfected mouse were harvested 
and the cellularity was measured. The total number of cells in the bone marrow 






























Figure 3.1: P. berghei infection time course 
 BALB/c mice were injected intraperitoneally with a dose of 1x106 P. berghei pRBCs 
on days 0, 1, 3 and 5. All mice were humanely killed on day 8 and thus had been infected 
for 8, 7, 5 or 3 days, respectively. Parasitemias were determined by Giemsa-stained 
blood smears (A) and the cellularity of the bone marrow (B) and spleen (C) were 
calculated. Each point represents the mean ± SEM, with n=6 for each group. An 
unpaired t-test was used to calculate statistical significance relative to day 0. *p<0.05, 







than the number of bone marrow cells in uninfected mice at 7 d.p.i. (Fig.3.1. B) In 
contrast, the number of cells in the spleen increased and reached significance by 7 
d.p.i. This is consistent with the observed splenomegaly in these mice (Fig.3.1. C).  
3.2.2. Changes in the erythroid population in the bone marrow and spleen 
during infection 
To specifically examine the erythroid lineage in the bone marrow and spleen, 
cells were labelled with CD44 and Ter119, markers previously used to differentiate 
various stages of erythroid precursor populations (Chen et al., 2009). Ter119 is 
expressed in erythroid cells at all stages of differentiation, from early proerythroblasts 
to mature erythrocyte stage (Kina et al., 2000). In contrast, CD44 expression (Kansas 
et al., 1990) and erythroblast size decreases progressively with maturation (Pootrakul 
et al., 2000). Therefore, Ter119-expressing cells can be differentiated into individual 
stages of maturation (proerythroblasts, basophilic erythroblasts, polychromatic 
erythroblasts, orthochromatic erythroblasts, reticulocytes and RBCs) based on size (as 
measured by FCS) and level of CD44 expression (Chen et al., 2009), as shown in Fig. 
3.2. In mice, proerythroblasts undergo three mitotic divisions as they sequentially 
differentiate into basophilic, polychromatic, and orthochromatic erythroblasts. Each 
proerythroblast divides to generate two basophilic erythroblasts, which subsequently 
divide to produce four polychromatic erythroblasts and these in turn divide to generate 
eight orthochromatic erythroblasts. Thus, it is expected that during normal steady-state 
erythropoiesis, the relative number of proerythroblasts, basophilic-, polychromatic- and 
orthochromatic erythroblasts follows a 1:2:4:8 ratio (Chen et al., 2009).  
The number of cells at each stage of erythroid differentiation following P. 
berghei were determined for both the bone marrow and spleen (Fig. 3.3) From these 
experiments, it was evident that the total number of erythroid cells in the bone marrow 
decreased steadily after infection, reaching significance from 3 d.p.i for reticulocytes 
and from 5 d.p.i onwards for proerythroblasts, basophilic-, polychromatic and 
orthochromatic erythroblasts and RBCs when the parasitemias were around 6 -7 %. 
Conversely, in the spleen, the erythroblast numbers subtly increased early on in the 
infection such that by 5 d.p.i the RBC numbers had significantly increased and by 7 


























Figure 3.2: Gating strategy for identifying distinct stages of erythroid 
differentiation in bone marrow and spleen 
Bone marrow and spleen cells were gated on size and granularity based on forward and 
side scatter (panel 1). Cells positive for Ter119 (PE-positive) were then gated (panel 2) 
and from these, distinct stages of erythroid differentiation were gated based on CD44 
expression and cell size (FSC-A) (panel 3). Shown is example of cells isolated from the 
bone marrow of uninfected BALB/c mice. Pro, proerythroblasts; Baso, basophilic 
erythroblasts; Poly, polychromatic erythroblasts; Ortho, orthochromatic erythroblasts; 
Retic, reticulocytes; RBC, red blood cells. 
Excluding cell debris Gating on Ter119+ve cells 
Gating on CD44 and size to identify 














































Figure 3.3: Evaluating various stages of erythropoiesis in the bone marrow and 
spleen of mice infected with P. berghei 
 The number of cells in the bone marrow and spleen at each distinct stage of erythrocyte 
maturation during an infection time course are shown. Data represents the mean ± SEM 
(n=6 independent experiments). A one-way ANOVA was used to determine statistical 























































Figure 3.4: Evaluating percentages of various stages of erythropoiesis per 106 cells 
in the bone marrow and spleen of mice infected with P. berghei 
The percentages in the bone marrow and spleen at each distinct stage of erythrocyte 
maturation during an infection time course are shown. Data represents the mean ± SEM 
(n=6 independent experiments). A one-way ANOVA was used to determine statistical 





There was however, decreased RBCs in spleen perhaps owing to splenic 
destruction of infected as well as uninfected RBCs. This represents induction of 
extramedullary erythropoiesis, which likely contributes to the enlarged spleen observed 
in mice infected for 8 days.  
The percentage of cells at each stage of erythropoiesis in the bone marrow and 
spleen were also calculated from the total Ter119+ parent population (Fig 3.4). For the 
proerythroblasts and basophilic populations in the bone marrow their percentages had 
subtly increased by 3 d.p.i, but by 5 d.p.i had significantly decreased. Although the 
same trend was observed for both the polychromatic and orthochromatic erythroblasts, 
the change to the percentage of these cells in the Ter119+ population was less 
pronounced and the reduction at 5 d.p.i was not significant. Similarly, the reduction in 
the reticulocyte percentage at 5 d.p.i was not significant. The percentages of RBCs in 
the bone marrow steadily decreased between 5 d.p.i and by 8 d.p.i and by this latter 
time point the decrease was significant. Interestingly, this coincided with an increase in 
the percentages of all the other erythroid populations from 5 d.p.i to 8 d.p.i, although 
the increase was only statistically significant for the orthochromatic erythroblast 
population, indicating that the bone marrow was attempting to mount a response to 
reduced numbers of RBCs.   
 The trend in the changes to the percentages of erythroblast populations in the 
spleen was very similar; notably there was a significant reduction at 5 d.p.i in the 
percentages of polychromatic and orthochromatic erythroblasts as well as reticulocytes 
but then between 5 d.p.i and 8 d.p.i there was a steady increase in the percentages of all 
erythroid populations when the percentage of RBCs had significantly decreased. 
3.2.3. Granulocyte, monocyte and megakaryocyte populations in bone 
marrow    and spleen during infection 
Erythrocytes, megakaryocytes, granulocytes and monocytes are all derived 
from a common hematopoietic progenitor cell in the bone marrow. Therefore, the total 
number of granulopoietic (Gr-1+), monocytic (CD11b+) and megakaryocytic cells 
(CD61+) in the bone marrow and spleen of uninfected mice (day 0) and infected mice 
(3, 5, 7 and 8 d.p.i) were also measured to gain a global perspective of haematopoiesis 



































Figure 3.5: Evaluation of the number of granulocytes (Gr-1+), monocytes 
(CD11b+) and megakaryocytes (CD61+) in the bone marrow and spleen of P. 
berghei infected mice 
 Data represents the mean ± SEM (n=6 independent experiments). A one-way 
ANOVA was used to determine statistical significance relative to day 0, *p<0.05, 















































Figure 3.6: Evaluation of the percentages of granulocytes (Gr-1+), monocytes 
(CD11b+) and megakaryocytes (CD61+) per 106 cells in the bone marrow and 
spleen of P. berghei infected mice 
Data represents the mean ± SEM (n=6 independent experiments). A one-way 
ANOVA was used to determine statistical significance relative to day 0, *p<0.05, 














































Figure 3.7: Comparison of erythropoiesis and myelopoiesis in the bone marrow of 
mice acutely infected with P. berghei 
 Stacked bars represent the relative abundance of erythroid (Ter119+), granulopoietic 
(Gr1+), monocytic (CD11-b+) and megakaryocytic (CD61+) populations in the bone 
marrow (A) and spleen (B).  Data represents the mean ± SEM (n=6 independent 
experiments) and was analysed by one-way ANOVA. *p<0.05, **p<0.01, ***p<0.001, 
****p <0.0001.  
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This revealed that not only were the numbers of Ter119+ cells in the bone 
marrow getting significantly smaller as the infection progressed, so too were the total 
numbers of Gr-1+, CD11b+ and CD61+ cell populations (Fig. 3.6).  Conversely, in the 
spleen there was a significant increase in all cell lineages beginning from 5 d.p.i (Fig. 
3.6). 
Taking into account that the overall cellularity of the bone marrow decreased 
during infection whilst that of the spleen increased (Fig. 3.1, Fig. 3.6), the percentage 
of Ter119+, Gr-1+, CD11b+ and CD61+ cell populations per 106 cells in the bone marrow 
or spleen were compared to examine how the proportions of these populations differed 
over the duration of the infection (Fig 3.7). This revealed that the percentage of the    
GR-1+, CD11b+ and CD61+ cellular compartments in the bone marrow significantly 
increased, particularly from 5 d.p.i, whilst the percentage of Ter119+ cells decreased. 
Similar results were observed in the spleen for the GR-1+, CD11b+ and CD61+ 
populations, except on 3 d.p.i, where there was a significant reduction in GR-1+ cells. 
However, in the spleen the overall percentage of Ter119+ cells remained relatively 
constant. The relative proportion of these four cell populations in the bone marrow and 
spleen is also shown in Fig. 3.7 and highlights that the overall proportion of Ter119+ 
cells in the bone marrow decreased during the course of infection while that of Gr-1+ 
and CD11b+ in particular increased. The changes to the proportion of the cell 
populations in the spleen were less striking. 
3.2.4. Differentiation of haematopoietic cells in the bone marrow during 
infection 
To investigate further how the relative proportions of the granulocyte, 
monocyte, megakaryocyte and erythroid lineages may be altered during the course of 
infection, bone marrow cells were isolated from uninfected mice and P. berghei 
infected mice at 4, 6 and 8 d.p.i and the ability of haematopoietic stem cells to 
differentiate into colony forming units was analysed. Specifically, the number of CFU-
GEMM (colony forming unit-granulocyte, erythroid, monocyte and megakaryocyte), 
CFU-GM (colony forming unit-granulocyte and macrophage), CFU-G (colony forming 
unit-granulocyte), CFU-M (colony forming unit-monocyte), BFU-E (burst forming 
















Figure 3.8: Differentiation of mouse hematopoietic stem cells into colony forming               
units 
 Mouse bone marrow cells were incubated in methyl cellulose medium for 8 -14 days. 
The colonies representing the common myeloid progenitor CFU-GEMM as well as 
BFU-E, CFU-E, CFU-GM, CFU-G and CFU-M were identified by microscopy under 

















































Figure 3.9: Total number of colony forming units in mouse bone marrow 
Colonies identified by microscopy were counted and plotted. Data represents the mean 
± SEM (n=4 independent experiments). A one-way ANOVA was used to determine 
















































Figure 3.10: Colony forming units per 105 bone marrow cells in mouse bone 
marrow 
Colonies identified by microscopy were counted and plotted. Data represents the mean 
± SEM (n=4 independent experiments). A one-way ANOVA was used to determine 




























Figure 3.11: Distribution of different colony forming units in the bone marrow of 
mice infected with P. berghei 
 Stacked bars represent relative proportion of colony forming units burst forming units 
of erythroid lineage (BFU-E), colony forming units of erythroid (CFU-E), monocytic 
(CFU-M), granulopoietic (CFU-G), granulopoietic and monocytic (GM), granulocytic, 




were identified based on their morphology (Fig. 3.8) and the total number of CFUs in 
the bone marrow cell were calculated (Fig 3.9) 
The total number of CFU-GEMM fluctuated with infection but had decreased 
significantly at 4 d.p.i and 8 d.p.i. The total numbers of CFU-GM and CFU-G were 
maintained during the infection until 6 d.p.i but by 8 d.p.i they had also significantly 
decreased. CFU-M numbers were already significantly reduced from 4 d.p.i onwards. 
The effect on total numbers of BFU-E was more striking and from 4 d.p.i onwards there 
was a large and very significant decrease. The numbers of CFU-E also reduced over 
time, with a significant reduction observed by 6 d.p.i.  
The relative frequencies of different CFUs per 1×105 cells were also determined 
(Fig.3.10). Although the numbers of CFU-GEMM were very low and therefore less 
reliable, it was interesting to note that at 6 d.p.i, the frequency of CFU-GEMM was 
approximately double that of uninfected mice before decreasing again to levels present 
prior to infection (Fig 3.10). This analysis revealed that whilst the proportion of CFU-
GM, CFU-G and CFU-M remained relatively stable during the course of infection or in 
some cases increased (e.g. CFU-G 8 d.p.i), the proportion of BFU-E at 4 d.p.i and 6 
d.p.i and CFU-E at 8 d.p.i were significantly reduced. This is also highlighted in Fig. 
3.11, where the frequency of the five CFU populations in the bone marrow relative to 
each other is plotted. This indicated that there was suppression of erythropoiesis in the 
bone marrow.  
3.2.5. Changes in pSTAT5 levels in bone marrow and spleen cells and 
erythroblasts during infection 
Erythropoiesis is regulated by signalling through the EPO receptor with STAT5 
responsible for the transcriptional activation of genes involved in erythropoiesis. For 
this reason, phosphorylated STAT5 (pSTAT5) levels were assessed in the erythroblast 
populations (proerythroblasts, basophilic-, polychromatic- and orthochromatic 
erythroblasts) to see if infection with P. berghei impacted on signalling through the 
EPO receptor. In addition, total pSTAT5 levels in the bone marrow and spleen were 
also measured, using the gating strategy outlined in Fig. 3.12. In the bone marrow, the 
pSTAT5 levels in erythroblasts as well as in the total bone marrow cell population 



















Figure 3.12: Gating strategy to detect pStat5 response in bone marrow and spleen 
cells and erythroblasts 
 Fixed and permeabilized cells (upper left panel) after doublet gating (upper middle 
panel) and fixable live/dead discrimination (upper right panel), were stained with 
CD44-APC and Ter119-PE to identify Ter119+ cells (lower left panel) and individual 
erythroblast stages (lower middle panel). Fixed and permeabilized cells were stained 
with pStat5-AF488 antibody (red histogram) and the negative population identified by 















Figure 3.13: pStat5 levels in Ter119+ erythroblasts and total cell populations 
isolated from the bone marrow and spleen 
 Total median fluorescence intensity for Ter119+ erythroblasts (left panel) and total cell 
populations (right panel) was calculated and plotted. Data represents the mean ± SEM 





significance, indicating the ability to signal through the EPO receptor did not appear to 
be affected. In the spleen, pSTAT5 levels were maintained up to 5 d.p.i, but intriguingly 
by 8 d.p.i they had significantly decreased in both the erythroblast population as well 
as in the total spleen cell population (Fig. 3.13). 
3.2.6. Investigation of whether P. berghei parasites can infect erythrocyte 
precursor to impact on erythropoiesis 
One mechanism by which erythropoiesis could potentially be altered during a 
malaria infection is if Plasmodium parasites infect erythroblasts and interfere with gene 
transcription and hence affect the proliferation, differentiation or survival of erythroid 
cells. Plasmodium parasites utilise surface receptors on host cells to invade but which 
surface receptors P. berghei utilises for invasion (and hence whether they are on blast 
cells) is unknown. To address, therefore, whether P. berghei can invade erythroblasts, 
mice were infected with P. berghei parasites expressing GFP to enable visualisation of 
the erythroid cells that had become infected. Specifically, a parasite line was used that 
had been modified at the Exported Protein 2 (EXP2). This line expresses both an 
mCherry (mCh) reporter and a GFP reporter, that latter of which is exported into the 
host cell in which the parasite resides.  
In order to obtain sufficient numbers of blast cells for analysis, the spleen was 
harvested rather than bone marrow from mice that had been infected with the GFP-
expressing P. berghei for 8 days. RBCs were removed by treatment with RBC lysis 
buffer. Cells were stained with anti-CD45 antibody to identify leukocytes, and 
populations negative for CD45 expression were selected.  The Ter119+ cells were then 
positively selection using Ter119+ magnetic beads. Since mature RBCs make up the 
vast bulk of the Ter119+ population, they were removed from the preparation by 
incubation in RBC lysis buffer, allowing enrichment of erythroblasts. The remaining 
Ter119+ cells were then analysed using flow cytometry (Fig. 3.14), utilising CD44 and 
Ter119 expression to identify erythroblasts, GFP expression to identify parasites, and 
DAPI staining to confirm that the cells were indeed nucleated blasts. The FACS 
analysis revealed that very few (<1%) proerythroblasts, basophilic- and polychromatic 
erythroblasts were positive for GFP. However, the number of orthochromatic 






















































































































































































































































































































































































Figure 3.15: P. berghei parasitism in mouse spleen erythroblasts  
Ter119+ cells isolated from spleens of BALB/c mouse ten days after infection with P. 
berghei-GFP. Cells stained with PE-conjugated Ter119, APC-conjugated CD44, 
AAPC-C7 conjugated CD45 and DAPI and were analysed using fluorescence 
microscopy. Images are representative of triplicate experiments.  
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To confirm these results, CD45-, Ter119+, GFP+ cells were sorted by FACS and 
collected cells were visualised by fluorescence microscopy (Fig. 3.16). However, the 
number of cells that were recovered after this procedure were low.  Moreover, despite 
attempts to enrich the blast population, the vast majority of the Ter119+ cells that were 
recovered and which had a bright GFP signal were infected reticulocytes or RBCs based 
on the DAPI staining and small cell size (see third row Fig. 3.16). Reticulocytes and 
RBCs can be distinguished from the blasts as they lack a nucleus and thus only the 
parasite nucleus, which is very small in comparison, stains with DAPI (compare rows 
one and two in Fig. 3.16). In contrast, infected erythroblasts are bigger in size, and 
contain a large nucleus that almost completely fills the cell as indicated by the DAPI 
staining. While a small number of the recovered cells did express GFP, the fluorescence 
was very low and barely above background fluorescence observed with uninfected 
RBC, making it difficult to confirm whether these cells were in fact infected with 
parasites. 
3.3 Discussion 
The severe anemia that arises in response to infection with Plasmodium parasites is 
thought to be due in part to inadequate erythropoiesis (Kurtzhals et al., 1997). To 
explore this further, the bone marrow and spleen of BALB/c mice were examined for 
cellularity and changes to erythropoiesis during the progression of an infection with P. 
berghei. This study found that the increase in parasitemia correlated with an overall 
decrease in mouse bone marrow cellularity of between 40% to 75%, which is consistent 
with reports of other studies (Rencricca and Coleman, 1979, Asami et al., 1992). 
Moreover, the number of erythroblasts decreased as the infection progressed, with each 
stage of erythroid development affected. However, examination of the proportion of the 
different erythroid stages, revealed that the earlier progenitor cells (proerythroblasts and 
basophilic erythroblasts) were the most impacted by 5 d.p.i. Nevertheless, the erythroid 
precursor cells were still able to mature in the bone marrow during a P. berghei 
infection. Taken together, this suggests that infection with P. berghei leads to a 
proliferative rather than a maturation defect in erythropoiesis in the bone marrow. 
In comparison to the bone marrow, the cellularity and the erythroblast 
population in the spleen significantly increased during the infection. However, the 
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changes to the proportion of the different erythroblast populations in the spleen were 
similar to the bone marrow and erythroblast maturation did not appear to be affected. 
The significant increase in the erythroblast population in the spleen but the reduction in 
RBCs by 8 d.p.i is in keeping with extramedullary erythropoiesis being triggered in 
malaria in response to anemia and the clearance of both uninfected (Evans et al., 2006) 
and infected RBCs (Chotivanich et al., 2002) in this organ, respectively. 
To assess the impact of infection on hematopoiesis more widely, the numbers 
of granulocytes, monocytes and megakaryocytes in the bone marrow and spleen were 
also compared to those of Ter119+ cells. This revealed that reduced cellularity of the 
bone marrow was also attributable to reduced numbers of granulocytes, monocytes and 
megakaryocytes in addition to the depletion of erythroid cells. Conversely, the increase 
in cellularity of the spleen was attributable to an increase in myeloid cells. Notably, in 
both organs the myeloid: erythroid ratio increased and was most pronounced at 8 d.p.i, 
as reflected by an increase in the percentage of granulocytes, monocytes and 
megakaryocytes relative to Ter119+ cells. Leukocyte counts, especially neutrophil 
granulocytes, have also been observed to be significantly higher in patients displaying 
high parasitemias during a malaria infection (McKenzie et al., 2005). It is perhaps not 
surprising that monocyte/macrophage numbers are increased in the spleen as they play 
an important role in removing circulating pRBC and uninfected RBC (Evans et al., 
2006). It is also interesting to point out that granulocytic production contributes to the 
release of inflammatory cytokines and chemokines that would further contribute to 
anemia, such as TNF- and IL-1 (Roodman et al., 1989, Lyke et al., 2004).  
The enumeration of hematopoietic progenitor cells in the bone marrow by 
colony forming assay enabled examination of why erythropoiesis is affected by 
infection. Whilst the total number of all the progenitor cells examined decreased during 
the course of infection (consistent with reduced cellularity of the bone marrow), the 
relative numbers of CFU-GM, CFU-M and CFU-G colonies tended to increase by 8 
d.p.i in response to infection, although only the increase in CFU-G was statistically 
significant. In contrast, the relative numbers of BFU-E were significantly depleted by 
4 and 6 d.p.i. Moreover, the proportion of CFU-E by 8 d.p.i was significantly reduced, 
which would also explain why the erythroblast populations were lowest at this time and 
suggests there was insufficient compensation for anemia through increasing conversion 
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to erythroblasts during the infection (Villeval et al., 1990b). This may explain why the 
proportion of BFU-E increased at 8 d.p.i and the impact of infection could be analogous 
to cases of chronic erythroid stress, such as hemolysis, where in response to low 
numbers of CFU-E progenitors there is insufficient production of RBCs despite high 
EPO levels, leading to the triggering of BFU-E production (Dolznig et al., 2006). 
Notably, a decrease in bone marrow cellularity, bone marrow BFU-E and CFU-E 
numbers have been observed previously in rodent malaria (Maggio-Price et al., 1985). 
The significant increase observed in the proportion of CFU-GEMM at 6 d.p.i, which 
differentiate into erythroid, megakaryocyte, monocyte and granulocyte colony forming 
units, is also interesting, as it suggests that the bone marrow is attempting to make a 
compensatory response during the course of infection. Nevertheless, the reduction in 
the total number of cells in the myeloid and erythroid lineage indicates the malaria 
infection is impacting on earlier progenitor cells in the hematopoietic pathway but that 
commitment of CFU-GEMM to the erythroid lineage is also perturbed. This is likely to 
be downstream of the erythroid-megakaryocyte precursor since the proportion of 
megakaryocytes increased relative to erythroblasts during the course of infection.  
What is the mechanism that could explain the reduced erythropoiesis in the bone 
marrow of infected mice? Although the serum levels of EPO were not measured in this 
study, it is unlikely that reduced levels of EPO were responsible for the reduction in the 
number of BFU-Es. This is because prior studies have already shown that EPO levels 
are not reduced in a Plasmodium infection; indeed some human studies have found 
increased EPO levels in infected patients (Kurtzhals et al., 1997) and a similar trend has 
been observed in P. chaubadi-infected mice (Chang and Stevenson, 2004). Rather, the 
depletion of BFU-E at 4 d.p.i and 6 d.p.i could be the result of their migration to the 
spleen, their destruction in the bone marrow or a shunt away from the erythroid pathway 
in favour of a myeloid response in an attempt to clear the infection. Any of these 
scenarios in turn would result in reduced blast populations in the bone marrow. The 
increase in splenic erythroblasts in the spleen suggests that the BFU-E and CFU-E are 
migrating to the spleen, although this was not formally explored in this study. Hence it 
would be interesting in future experiments to compare the BFU-E and CFU-E numbers 
in the spleen and bone marrow. Other studies (non-malaria) examining blood loss and 
anemia have also suggested that the reduced numbers of BFU-E in the bone marrow 
may be due to their migration to spleen and their differentiation to CFU-E in the marrow 
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(Hara and Ogawa, 1976, Iscove, 1977). It would be interesting to see whether the 
increase in BFU-E on 8 d.p.i led to significantly low CFU-E numbers on that day. A 
comparison of spleen CFUs during the infection time course could help understand if 
there is a corresponding increase/decrease of them during the infection.  Also, it would 
be interesting to see what happens to the numbers of CFU-Es after 8 d.p.i and whether 
there is apoptosis of HSC or BFU-Es in the bone marrow. 
Given the importance of STAT5 in the development of the haematopoietic 
system, including in HSC, lymphocyte, and erythrocyte development (Li et al., Zhu et 
al., 2008), it was of interest to examine the pSTAT5 levels in the bone marrow and 
spleen erythroblasts as well as in the total cell population. In the erythroid compartment, 
for example, activated STAT5 plays a significant anti-apoptotic role by upregulating 
Bcl-Xl (Socolovsky et al., 2001, Zhu et al., 2008, Nosaka et al., 1999) whereas enforced 
suppression of STAT5 expression impairs long-term self-renewal and maintenance of 
human stem and progenitor cells (Schepers et al., 2007). Moreover, STAT5-negative 
regulation has been shown to trigger emergency granulopoiesis (Fievez et al., 2007) but 
not myelopoiesis (Li et al., 2007), whereas  persistent activation of STAT5A in human 
hematopoietic stem and progenitor cells results in their enhanced self-renewal and a 
diversion towards differentiation to the erythroid lineage (Schuringa et al., 2004). 
However, in this study, pSTAT5 levels were not significantly altered in either the bone 
marrow or specifically in the bone marrow erythroblasts of infected mice relative to 
uninfected mice, indicating there was no substantial change in the flux through this 
pathway in bone marrow during infection. There was, however, a decrease in pSTAT5 
levels in spleen cells and splenic erythroblasts by 8 d.p.i, in spite of substantial 
extramedullary erythropoiesis in this organ. It is interesting to note, however, that low 
to intermediate pSTAT5 activity favours the self-renewal of stem and progenitor cells 
in combination with long-term expansion, whereas high STAT5 activity levels results 
in a major commitment towards erythroid lineage, combined with impaired myeloid 
development (Wierenga et al., 2008). In this study, the reduced pSTAT5 levels in the 
total splenocytes and splenic erythroblasts at 8 d.p.i correlated with an increasing 
myeloid response to infection as well as increased numbers of spleen erythroblasts.  
Finally, it is known that P. berghei has a preference for invading reticulocytes 
but this species can also infect mature RBC. However, it has not been shown 
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previously whether P. berghei can infect erythroblasts and potentially affect 
transcriptional activity and influence their normal development. This study 
demonstrated that although the percentage of infected pro-erythroblasts, basophilic and 
polychromatic erythroblasts were very low, a considerable number of orthochromatic 
erythroblasts were potentially infected. In this study GFP expressing parasites were 
used to examine the infection of erythroblasts with P. berghei. Whilst GFP 
fluorescence was readily visible by FACS analysis, by microscopy the level of 
fluorescence was very low. The latter may be because the GFP reporter, which was 
designed to be exported into the host cell, is diluted in the large blast cells compared 
to reticulocytes/mature RBC and thus more difficult to visualize. It will be important, 
therefore, to confirm that this signal is real and that blasts can indeed be infected with 
P. berghei by using another reporter that is retained within the parasite and which gives 
a brighter fluorescence signal. There have been previous reports that both P. 
falciparum and P. vivax can invade erythroblasts in vitro (Tamez et al., 2009, 
Panichakul et al., 2007), and parasitized erythroblasts have also been observed within 
the bone marrow of patients with vivax malaria (Ru et al., 2009). Moreover, 
hematopoietic suppression-associated genes such as JUN and RARA have been 
shown to be induced in P. falciparum-parasitized erythroblasts (Tamez et al., 2011). 
However, P. falciparum cell division has only been observed in orthochromatic 
erythroblasts which enucleates and differentiates into reticulocytes (Tamez et al., 
2011) despite the fact that glycophorin A, which P. falciparum uses to invade RBCs, 
is already expressed at the pro-erythroblast stage (Lamikanra et al., 2007). Thus, 
while it remains plausible that Plasmodium infection of blasts can impact on 
erythropoiesis, the low numbers of infected blasts, particularly those at the earliest 
stages of erythropoiesis, suggests that the impact is likely to be minimal.  
In conclusion, the present study provided an insight into the changes occurring 
in the bone marrow and spleen of mice succumbing to anemia due to an acute P. berghei 
infection. Through the identification of the individual blast cells, it was possible to 
examine both the proliferation and differentiation of these cells. An increased 
parasitemia led to decreased cellularity in the bone marrow and a depletion of CFU-E 
resulted in the production of fewer number of blasts cells as the infection progressed. 
Whilst the proportion of erythroid cells decreased in the bone marrow, the proportion 
of megakaryocytes and myeloid cells increased, the latter a likely host response to help 
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clear the infection but also a generator of inflammatory cytokines that in turn contribute 
to anemia. It is unlikely that infection of erythroblasts contributes to this proliferative 
defect since only cells from the later orthochromatic stage were possibly infected. 
Finally, a decreased STAT5 levels in spleen are indicating a defective iron uptake in 
spite of extramedullary erythropoiesis but further investigations need to be performed 
to check other aspects leading to anemia and the role of SOCs proteins as well as CISH 
as they regulate STAT5 levels.  








Investigating the role of CISH in 
susceptibility to malaria infection and 
development of anemia  
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4.1. Introduction  
Cytokine-inducible Src homology 2 domain-containing protein (CISH) is a 
member of the suppressor of cytokine signaling (SOCS) family of negative regulators 
and is induced by EPO, GM-CSF, G-CSF, IL-2, IL-3, IL-4, IL-15 and T cell receptor 
signaling (Matsumoto et al., 1997, Yoshimura et al., 1995, Hunter et al., 2004, Li et al., 
2000). Single nucleotide polymorphisms (SNPs) in the human CISH gene have been 
associated with susceptibility to severe manifestations of malaria infections (Khor et 
al., 2010). One manifestation of malaria is severe malaria anemia but how CISH may 
contribute to this or other pathological outcomes remains to be investigated. Thus, to 
directly examine the influence of CISH in malaria infections, the outcome of P. berghei 
infection was analysed in BALB/C mice (which typically succumb to severe malaria 
anemia) that are deficient for CISH. Specifically, the impact of CISH deficiency on 
erythropoiesis, various haematological parameters and serum cytokine responses was 
investigated, and the development of anemia and parasitemia in an acute rodent malaria 
model of infection was also assessed.  
4.2. Results  
4.2.1. Outcome of infection 
BALB/c Cish+/+ and Cish-/- littermates in groups of up to ten were infected with 
1 × 106 P. berghei ANKA-infected RBCs by intraperitoneal injection.  Both male and 
female mice were used where possible as ongoing studies on these mice indicate that 
there is variation in particular parameters such as adiposity between Cish+/+ and Cish-/- 
mice that is sex-dependent (Saeed Maymand, PhD thesis under preparation).  
After infection, no significant differences in the time course of parasitemia were 
observed between Cish+/+ and Cish-/- mice, either in female or male mice (Fig. 4.1A). 
This suggests that CISH in not a crucial determinant of parasite load during a malaria 
infection.  Within the first 3-5 days post infection (d.p.i.), both sexes showed an initial 
slight increase in bodyweight but by later time points their bodyweight had decreased. 
Whilst this decrease occurred slightly earlier in the females compared to the males, no 
significant difference was observed in the amount of weight lost between the genotypes 
(Fig. 4.1B).  
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            4.2.2. Impact of P. berghei infection on other blood cell parameters 
The changes in haemoglobin levels prompted analysis of other peripheral blood 
parameters, including white blood cell (WBC, consisting of neutrophils, lymphocytes, 
monocytes, eosinophils and basophils), platelet and red blood cell (RBC) counts, as 
well as RBC size, volume and hemoglobin content (Fig. 4.2). Uninfected female      
Cish-/- mice exhibited significantly lower RBC counts, haematocrit and haemoglobin 
levels than their Cish+/+ female counterparts, although the cells were still normochromic 
and normocytic as indicated by the MCH, MCHC and MCV levels. Interestingly, the 
RBC counts, haematocrit and hemoglobin levels did not significantly change in the 
female Cish-/- mice throughout the infection period while those of the female Cish+/+ 
decreased to levels significantly lower than in their knockout counterparts. Platelet 
counts were comparable in uninfected animals and decreased to a similar extent during 
early infection, but the recovery of platelet count was significantly stronger in the Cish 
-/- mice than the Cish +/+ mice. In the female Cish+/+ mice, the number of WBCs increased 
during the course of infection as expected and similar results were obtained for the Cish-
/- mice. 
For the male mice, the uninfected Cish -/- mice exhibited significantly lower 
RBC count and haematocrit compared to uninfected Cish+/+ mice but they were still 
normochromic and normocytic. However, both parameters were similar to those 
observed in Cish+/+ mice by 7 d.p.i. The uninfected Cish-/- mice also had reduced WBC 
and platelets, with the WBC not increasing to the same extent as their Cish+/+ 
counterparts upon infection. 
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Figure 4.1: Effects of P. berghei infection of Cish+/+ and Cish -/- BALB/c mice 
Female (right panels) and male (left panels) Cish+/+ (WT) and Cish-/- (KO) mice 
injected intraperitoneally with 1×106 iRBC were monitored for parasitemia (A) and 
change in body weight (B). Statistical significance was determined by t-test, with 
**p<0.01, ***p<0.001 and ****p<0.0001. WT females n=10, KO females n=10, WT 





Figure 4.2: Effect of P. berghei infection on blood parameters of Cish+/+ and       
Cish-/- mice  
Blood was collected from female (left panel) and male (right panel) Cish+/+ (WT) and 
Cish-/- (KO) mice prior to infection (D0) and at 5 d.p.i. (D5) or 7 d.p.i. (D7) and 
analysed for white blood cell count (WBC), RBC count, haemoglobin (Hgb), 
haematocrit (HCT), platelets (Plt), mean corpuscular haemoglobin (MCH), mean 
corpuscular volume (MCV) and mean corpuscular haemoglobin concentration 
(MCHC). Data represent mean ± SEM and statistical significance was obtained using 




4.2.3. Impact of P. berghei infection on bone marrow haematopoiesis of 
Cish+/+ and Cish-/- mice  
The total number of bone marrow cells (from both tibia and femur) were 
measured in female and male mice of both genotypes (Fig. 4.3A). No significance 
difference was observed in the cellularity between Cish-/- and Cish+/+ mice of either sex 
before and after infection. Notably upon infection, the bone marrow cellularity of all 
mice significantly decreased.  
To gain a global picture of how CISH impacts bone marrow haematopoiesis 
during infection, cells belonging to the granulocyte (Gr+), megakaryocyte (CD61+), 
monocyte (CD11b+) and erythrocyte (Ter119+) lineages were measured in mice that 
were uninfected (D0) or at 7 d.p.i. (D7) for each genotype and sex. This revealed sex-
dependent differences in bone marrow haematopoiesis. 
Uninfected female Cish-/- mice had significantly higher CD11b+ cells and 
significantly lower Ter119+ cells than female Cish+/+ mice (Fig. 4B). Following 
infection, all populations decreased in total number, consistent with the decreased 
overall cellularity, with the exception of Ter119+ cells in the female Cish-/- mice which 
were not markedly reduced upon infection, such that they were no longer significantly 
different to Cish+/+ mice. When expressed as a percentage, uninfected female Cish-/- 
exhibited elevated Gr-1+, CD11b+ and CD61+ and reduced Ter119+ cell populations 
relative to their wildtype counterparts (Fig. 4.3C). Following infection of Cish+/+ mice, 
the percentage of Gr-1+, CD11b+ and CD61+ cells all increased significantly, while the 
percentage of Ter119+ cells decreased. Notably, the percentage of Ter119+ cells 
increased in Cish-/- females, while the changes in the other populations were such that 
they were no longer statistically different from Cish+/+ mice. 
In contrast, no significant differences were observed between male Cish+/+ and 
Cish-/- mice, either basally or after infection in terms of overall cellularity (Fig 4.3A), 
or with respect to the different cell populations in either total numbers (Fig 4.3B) or 
relative percentage (Fig 4.3C). The changes following infection essentially mirrored 
those observed in female Cish+/+ mice with the exception of the relative percentage of 





Figure 4.3: Comparison of cellularity and granulocyte (Gr-1+), monocyte 
(CD11b+), megakaryocyte (CD61+) and erythroid (Ter119+) cell populations and 
relative percentages in the bone marrow of Cish+/+ and Cish-/- mice. Cellularity (A), 
total cell counts (B) and percentage per 106 cells (C) in the bone marrow of Cish+/+ 
(WT) and Cish-/- (KO) female (left panel) and male mice (right panel) were calculated 
before infection (D0) and at 7 d.p.i. (D7). Data represent mean ± SEM (n=6 independent 
experiments) and statistical significance was obtained using one-way ANOVA.   





Figure 4.4: Comparison of cellularity and granulocyte (Gr-1+), monocyte 
(CD11b+), megakaryocyte (CD61+) and erythroid (Ter119+) cell populations and 
relative percentages in the spleen of Cish+/+ and Cish-/- mice 
 Cellularity (A), total cell counts (B) and percentage per 106 cells (C) in the spleen of 
Cish+/+ (WT) and Cish-/- (KO) female (left panel) and male mice (right panel) were 
calculated before infection (D0) and at 7 d.p.i. (D7). Data represent mean ± SEM (n=6 
independent experiments) and statistical significance was obtained using one-way 




4.2.4. Impact of P. berghei infection on splenic hematopoiesis in Cish+/+ 
and Cish-/- mice 
Similar analysis of splenic haematopoiesis also revealed changes between 
Cish+/+ and Cish-/- animals that was restricted to female mice. Spleens from uninfected 
female Cish-/- mice exhibited a greater cellularity than those of Cish+/+ mice (Fig. 4.4A). 
This was attributable to increased Gr-1+, CD11b+ and Ter119+ cells in terms of both 
total cell number (Fig. 4.4B) and percentage (Fig. 4.4C). Infection led to a significant 
increase in cellularity of the spleen (Fig. 4.5A), consistent with overt splenomegaly 
(data not shown). This was attributable to an increase in all cell populations analysed 
(Gr-1+, CD11b+, CD61+ and Ter119+ cells) (Fig. 4.4B). Analysis of the relative 
percentages revealed a significant increase in Gr-1+, CD11b+ cells and Ter119+ in 
uninfected Cish-/- females compared to uninfected Cish+/+ females (Fig. 4.4C). Once 
again there was no significant differences between male Cish+/+ and Cish-/- mice for any 
of the parameters (Fig. 4.4A-C), with infection resulting in no significant changes 
amongst the different cell populations (Fig. 4.4C).   
4.2.5. Impact of P. berghei infection on bone marrow erythroid populations 
in Cish+/+ and Cish-/- mice 
To further investigate the effects on erythropoiesis, the bone marrow of 
uninfected and infected Cish+/+ and Cish-/- mice was analysed using Ter119/CD44 
double staining, as described (Chen et al., 2009), to quantify each stage of 
erythropoietic development.  
Uninfected Cish-/- females had significantly higher basophilic, polychromatic 
and orthochromatic erythroblasts but significantly lower mature RBC in their bone 
marrow compared to uninfected Cish+/+ females in terms of both number (Fig. 4.5A) 
and relative percentage (Fig. 4.5B). Following infection, female mice of both genotypes 
had significantly depleted numbers of each erythroblast stage and reticulocytes, 
although the Cish-/- mice retained significantly higher numbers of proerythroblasts, 
orthochromatic erythroblasts and reticulocytes than their wildtype counterparts at 7 




Figure 4.5: Impact on P. berghei infection on erythropoiesis in the bone marrow 
of Cish+/+ and Cish-/- mice 
The total number of cells at each distinct stage of erythrocyte maturation (A) and the 
percentage per 106 cells (B) in the bone marrow of female (left panel) and male (right 
panel) Cish+/+ (WT) and Cish-/- (KO) mice are shown for uninfected mice (D0) and 
mice at 7 d.p.i. (D7). Data represents the mean ± SEM (n=6 independent experiments) 





Figure 4.6: Impact on P. berghei infection on erythropoiesis in the spleen of Cish+/+ 
and Cish-/- mice  
The total number of cells at each distinct stage of erythrocyte maturation (A) and the 
percentage per 106 cells (B) in the spleen of female (left panel) and male (right panel) 
Cish+/+ (WT) and Cish-/- (KO) mice are shown for uninfected mice (D0) and mice at 7 
d.p.i. (D7). Data represents the mean ± SEM (n=6 independent experiments) and was 
analysed by one-way ANOVA. *p<0.05, **p<0.01, ***p<0.001, ****p <0.0001. 
Chapter 4 
 75 
consistent with the results of the peripheral RBC counts presented in Fig. 4.2. In 
percentage terms, Cish+/+ females showed a significant reduction only in reticulocytes 
and RBCs as a consequence of infection, but this decrease was not observed in Cish-/- 
females. In contrast, males of both genotypes displayed similar basal numbers of all 
erythrocyte populations, with infection causing a similar depletion polychromatic 
erythroblasts, reticulocytes and RBCs, with the basophilic erythroblasts also 
significantly depleted only in the male Cish-/- mice by 7 d.p.i. (Fig. 4.5A). No significant 
differences were observed in the percentages of the various erythrocyte populations 
between the uninfected and infected males of both genotypes (Fig. 4.5B).  
4.2.6. Impact of P. berghei infection on the splenic erythroid populations in 
Cish+/+ and Cish-/- mice 
In contrast to the bone marrow, no significant difference was observed in the 
basal levels of each erythrocyte population in the spleen between the Cish+/+ and Cish-
/- mice of either sex (Fig. 4.6). Following infection, all mice, irrespective of sex and 
genotype, displayed a significant increase in the number of each blast population, 
although this was more pronounced for the orthochromatic erythroblasts and 
reticulocytes in the female Cish-/- mice compared to their wildtype counterpart (Fig. 
4.6A). With respect to the percentage of each population, the earlier blast stages were 
increased upon infection in all mice, with the frequencies of the polychromatic and 
orthochromatic erythroblasts more elevated in the infected female Cish-/- mice than their 
wild-type counterparts (Fig. 4.6B). In contrast, the proportion of mature RBCs declined, 
most likely due to clearance of both infected and uninfected RBCs from the spleen.  
4.2.7. Impact of P. berghei infection on the differentiation of hematopoietic 
precursors in the bone marrow of Cish+/+ and Cish-/- mice 
Given the altered haematopoiesis observed between Cish+/+ and Cish-/- mice, 
particularly in the bone marrow, hematopoietic progenitor cells (CFU-GEMM, CFU-





















Figure 4.7: Comparison of total number of colony forming units of each lineage in 
the bone marrow between Cish-/- and Cish+/+ mice infected with P. berghei 
 Colonies identified by microscopy were counted and plotted. Data represents the mean 
± SEM (n=4 independent experiments) and was analysed by one-way ANOVA. 

























Figure 4.8: Comparison of number of colony forming units of each lineage per 105 
cells in the bone marrow between Cish -/- and Cish +/+ mice infected with P. berghei 
Colonies identified by microscopy were counted and plotted. Data represents the mean 
± SEM (n=4 independent experiments) and was analysed by one-way ANOVA. 
*p<0.05, **p<0.01, ***p<0.001, ****p <0.0001.  
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Uninfected Cish-/- females possessed more CFU-G, but fewer CFU-M, BFU-E 
and CFU-E colonies, when assessed by total number (Fig. 4.7) or frequency (Fig. 4.8). 
Following infection, both genotypes showed no change in the total number and 
frequency of CFU-GEMM, while CFU-GMs were decreased in number, but not 
frequency. The total CFU-G numbers were significantly reduced only in Cish-/- mice, 
although frequency was increased in mice, while CFU-E were reduced in total number 
and frequency in both genotypes. This meant that there were no significant differences 
in the numbers of any population between genotypes at 7 d.p.i. 
Uninfected male Cish mice showed significantly increased total CFU-M but not 
frequency compared to wild-type counterparts. Following infection, CFU-GEMM and 
CFU-GM were not significantly changed in male mice of both genotypes in terms of 
total number or frequency, although CFU-GM frequency was significantly increased in 
Cish-/- mice compared to Cish+/+ mice by 7 d.p.i. Moreover, there was a trend for a 
reduction in total CFU-G in Cish-/- mice, such that the difference compared to Cish+/+ 
mice also reached significance by 7 d.p.i. On the other hand, CFU-M decreased in Cish-
/- mice, meaning they were no longer elevated compared to wild-type mice. No 
significant changes in BFU-E were observed, but CFU-E were decreased in both 
genotypes in terms of number and frequency, resulting in no significant difference 
between Cish+/+and Cish-/- mice at 7 d.p.i. 
4.2.8. Impact of P. berghei infection on the pSTAT5 levels in the spleen and 
in splenic erythroblasts of Cish +/+ and Cish -/- mice 
CISH is a negative regulator of STAT5 whose activity is critical for both 
erythropoiesis and granulopoiesis. It was, therefore, interesting to evaluate the 
differences in phospho-STAT5 (pSTAT5) levels in the Cish+/+ and Cish-/- mice. This 
was undertaken in female mice only and on spleen cells given the higher number of 
cells that could be extracted from uninfected and infected mice (Fig. 4.9). This revealed 
that there was no difference in the total pSTAT5 levels in the uninfected Cish-/- and 
Cish+/+ spleen cells. With the infection, pSTAT5 levels similarly decreased in females 
of both genotypes.



























Figure 4.9: Comparison of pStat5 response in Cish +/+ and Cish -/- female mice in 
spleen cells and isolated erythroblasts with P. berghei infection  
Total median fluorescence intensity for each population was calculated and plotted. 
Data represents the mean (SEM (n= 6 for each group) and statistical significance was 


































Figure 4.10: Comparison of serum pro-inflammatory cytokines in Cish +/+ and 
Cish -/- mice after P. berghei infection  
Serum was collected prior to infection with 1x106 P. berghei ANKA (pre-bleed) and 
upon culling the mice at 7 d.p.i. (final bleed) and analysed for cytokine levels using 
ELISA. Data represents mean ± SD WT female PRE and FINAL n=6, KO female 
PRE n=6, FINAL = 5, WT male PRE n=6 FINAL n=8, KO male PRE n=9 FINAL 
n=7) and statistical significance was measured using a one-way ANOVA. *p<0.05, 









Figure 4.11: Comparison of serum chemokine cytokines in Cish +/+ and Cish -/- mice 
after P. berghei infection 
 Serum was collected prior to infection with 1x106 P. berghei ANKA (pre-bleed) and 
upon culling the mice at 7 d.p.i. (final bleed) and analysed for cytokine levels using 
ELISA. Data represents mean ± SD WT female PRE-and FINAL n=6, KO female PRE-
n=6, FINAL = 5, WT male PRE n=6 FINAL n=8, KO male PRE n=9 FINAL n=7) and 























Figure 4.12: Comparison of serum anti-inflammatory cytokines in Cish +/+ and 
Cish -/- mice after P. berghei infection  
Serum was collected prior to infection with 1x106 P. berghei ANKA (pre-bleed) and 
upon culling the mice at 7 d.p.i. (final bleed) and analysed for cytokine levels using 
ELISA. Data represents mean ± SD WT female PRE and FINAL n=6, KO female PRE 
n=6, FINAL = 5, WT male PRE n=6 FINAL n=8, KO male PRE n=9 FINAL n=7) and 






However, when the pSTAT5 levels of the erythroblasts were evaluated, uninfected 
Cish-/- females had significantly lower pSTAT5 levels compared to the uninfected 
Cish+/+ erythroblasts. Nonetheless, with the infection the pSTAT5 levels decreased in 
both the genotypes in a similar fashion.  
4.2.9. Serum cytokine and chemokine analysis  
Since cytokines play significant role in determining the outcome of a 
Plasmodium infection and CISH negatively regulates the signalling of various cytokine 
receptors, serum cytokines were also analysed prior to infection in comparison to 
samples taken at 7 d.p.i.  
Amongst pro-inflammatory cytokines, basal levels of IL-2 were elevated just in 
female Cish-/- mice, while IL-23 was elevated in Cish-/- mice of both sexes compared to 
their respective wild-type counterparts (Fig. 4.10).  Following infection, IL-6, IL-18, 
IFN- and TNF were all significantly increased in both genotypes and both sexes, 
while IL-9 showed a trend for an increase that reached significance only in Cish+/+ 
males. IL-23 increased only in wild-type mice of both sexes, leading to a significant 
increase in female Cish+/+ mice compared to their knockout counterparts, whereas IL-
17 was only increased in female Cish+/+ mice. 
Among the chemokines no difference was observed in basal levels across all 
mice (Fig. 4.11). Following infection, female Cish+/+ mice showed significantly 
increased levels of IP-10, RANTES, and MIP-2, but these did not reach significance 
compared to Cish-/- mice. In contrast, Cish-/- females showed a significant increase of 
MCP-1, MCP-3 and MIP-1 levels to be significantly elevated relative to Cish+/+ 
females by 7 d.p.i., while both female genotypes showed an equivalent increase in MIP-
1 levels. Males of both genotypes showed a similar chemokine response with 
infection. For example, RANTES, MCP-1, MIP-1 and MIP-1 levels were 
significantly increased in males irrespective of genotype. Moreover, although levels of 
MCP-3 and MIP-2 significantly increased only in Cish+/+ males, there was a trend for 
an increase in Cish-/- males, such that there was no difference in any chemokines 
between genotypes by 7 d.p.i.  
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Among the anti-inflammatory cytokines, basal levels were only different for IL-
5, being significantly increased only in female Cish-/- mice compared to Cish+/+ females 
(Fig. 4.12). Following infection, IL-10 increased significantly in mice of both 
genotypes and sexes. In contrast, IL-27 was only increased in Cish-/- females and IL-5 
in Cish-/- males. But, again there were no significant difference between Cish+/+ and 
Cish-/- mice of either sex by 7 d.p.i.   
4.3 Discussion 
Anemia has been well studied in malaria and several animal models have thrown light 
on the role of numerous cytokines involved in the development of anemia in malaria 
(Were et al., 2006, Awandare et al., 2009, Ouma et al., 2008, Keller et al., 2006). 
Cytokine signaling through the JAK-STAT pathway is regulated by SOCS proteins, 
including CISH. However, how SNPs in the human CISH gene promoter contribute to 
an increased susceptibility to severe malaria anemia is not known. This Chapter 
attempted to partially address this question by examining the consequence of infection 
with P. berghei in Cish+/+ and Cish-/- mice with regards to the time-course of 
parasitemia and development of anemia, along with the analysis of additional 
hematological parameters, erythropoiesis, granulopoiesis, myelopoiesis and 
megakaryopoiesis in the bone marrow and spleen, along with serum cytokine levels. 
Significant differences were observed in a variety of hematological parameters 
between uninfected female Cish+/+ and Cish -/- mice. Lower numbers and frequency of 
BFU-E and CFU-E were observed in the bone marrow of female Cish -/- mice, and 
although some erythroblast populations were elevated, RBC numbers were also 
reduced, resulting in an overall reduction in the Ter119+ population. Since the bone 
marrow is the major contributor to basal erythropoiesis, this explains the reduced RBC 
count, hemoglobin levels and hematocrit in the peripheral blood, especially since basal 
erythropoiesis in the spleen appeared normal. Other hematopoietic cell populations 
were also affected in the bone marrow, with GR-1+, CD11b+ and CD61+ all elevated in 
female Cish-/- mice, as were CFU-G, although CFU-M were reduced and peripheral 
WBC and platelet numbers remained unaltered. The cellularity of the spleen of 
uninfected female Cish-/- mice was also increased compared to wild-type counterparts, 
with the numbers and frequency of GR-1+ and CD11b+ populations elevated, as were 
the number of Ter119+ cells. Some differences were also observed between uninfected 
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male Cish+/+ and Cish-/- mice. Like female Cish-/- mice, male Cish-/- mice also exhibited 
reduced RBCs and hematocrit levels in the peripheral blood, but without significant 
changes in erythroid populations in the bone marrow or spleen. They additionally had 
reduced peripheral WBC and platelet counts and elevated numbers of CFU-M in the 
bone marrow. The reason for these sex-specific differences has yet to be ascertained 
but highlights the importance of analysing both sexes in studies such as these. 
Despite the reduced basal erythropoiesis in female Cish-/- mice, when infected 
with P.  berghei these mice displayed higher numbers of proerythroblasts, basophilic 
and orthochromatic erythroblasts and reticulocytes in comparison to the Cish+/+ mice, 
allowing the knockouts to increase RBC production so that they succumbed to anemia 
less rapidly than their wildtype counterparts. This was opposite to our initial hypothesis 
that these mice would succumb to anemia more rapidly. Nevertheless, this did not lead 
to a significant impact on the wellbeing of the animals, which lost a similar amount of 
bodyweight to the Cish+/+ mice and the course of parasitemia was also comparable. 
Moreover, mice of both genotypes exhibited comparable elevations of specific 
cytokines that have been previously shown to be associated with anemia, including 
IFN-, TNF- and IL-6 (Chopra et al., 2015, Lyke et al., 2004) consistent with the 
outcomes observed. Only limited differences were observed between male Cish+/+ and 
Cish-/- mice following infection, and these affected non-erythroid lineages, with again 
no effect on anemia susceptibility. Collectively, this argues against a role for CISH in 
severe malaria anemia. However, the P. berghei infection model is an acute infection 
model and this could be one reason why no difference in pathological outcomes was 
observed. It would, therefore, be interesting to examine the impact of the lower basal 
BFU-E and CFU-E in the bone marrow and RBC numbers in female Cish-/- mice on the 
development of severe malaria anemia in a chronic malaria infection model (e.g. P. 
chabaudi), as this may exert more stress on the maintenance of erythropoiesis, 
potentially leading to more adverse outcomes for the mice. 
STAT5 is a key regulator of erythropoiesis (Pallard et al., 1995, Longmore, 
2006). Erythroblast maturation in Stat5a-/-Stat5b-/- mouse hematopoietic tissue shows a 
dramatic increase in the relative number of early erythroblast due to a block in 
differentiation (Socolovsky et al., 1999). STAT5 plays a significant anti-apoptotic role 
in erythroid cells by upregulating Bcl-XL (Socolovsky et al., 2001, Zhu et al., 2008, 
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Nosaka et al., 1999). Conversely, overexpression of Bcl-XL, in erythroid cells can 
trigger erythroid maturation independent of EPO (Dolznig et al., 2002, Garcon et al., 
2006). CISH has been identified as a negative regulator of EPO-R-induced STAT5 
activation in vitro (Yoshimura et al., 1995), which may explain differences observed in 
the erythroid lineage in Cish-/- mice relative to their wildtype counterparts both before 
and during infection. Therefore, attempts were made to evaluate potential differences 
in levels of STAT5 activation between Cish+/+ and Cish-/- mice. This was undertaken in 
female mice, since these showed the greatest difference between genotypes using spleen 
cells which could be extracted in high numbers from uninfected and infected mice. 
Also, owing to reduced cellularity as well as erythroblast numbers in the bone marrow, 
only spleen cells were analysed. This revealed no difference in the overall STAT5 
phosphorylation (pSTAT5) levels in the uninfected Cish+/+ and Cish-/- mice (Fig. 4.9), 
which decreased similar in both genotypes following infection. However, when 
Ter119+ erythroblasts were specifically evaluated, uninfected Cish-/- females showed 
significantly lower pSTAT5 levels compared to their wild-type counterparts, although 
following infection decreased in both the genotypes to a similar level. The lower basal 
pSTAT5 levels in Cish-/- mice was surprising, and warrants further study. One 
possibility is that other SOCS family members are affected, such as SOCS3, which is 
another negative regulator of STAT5 (Porpiglia et al., 2012). However, the reduced 
STAT5 activation may help explain the defective late erythropoiesis in the Cish-/- 
females, which have elevated erythroblasts, but fewer mature RBC.  
It is possible that the disrupted erythropoiesis in Cish-/- mice may not be due to 
its direct (‘cell autonomous’) action on erythroid cells, but rather a consequence of its 
action on other cells that impact indirectly (‘non-cell autonomously’). For example, IL-
l has been shown to have a myelo-potentiating effect on hematopoiesis (Moore and 
Warren, 1987). This cytokine significantly suppresses late-stage erythropoiesis in mice, 
but leads to an increase in the number of immature erythroid progenitors, as well as 
granulocytic, monocytic, and megakaryocytic precursors (Johnson et al., 1989). IL-1 
is produced mainly by macrophages and monocytes (Gery et al., 1972), with the 
elevated frequencies of CD11b+ cells in female Cish-/- mice potentially leading to 
increased production of this cytokine, ultimately leading to decreased number of mature 
erythrocytes. There are a variety of other such possibilities, and it would be interesting 
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to compare the different genotypes for other factors such as IL-1levels that are known 
to impact on hematopoiesis.   
Indeed, changes in several cytokines was observed. The levels of IL-2, IL-5 and 
IL-23 were found to be significantly elevated in uninfected female Cish-/- mice. IL-2 is 
involved in T lymphocyte production (Smith, 1988), while IL-23 is crucial in expanding 
and maintaining the Th17 cell population which is involved in immune responses 
against infection (McGeachy and Cua, 2008). While these specific populations were 
not investigated, the significantly higher CD11b+ numbers in uninfected Cish-/- mice 
could provide the explanation at least for the elevated basal IL-23 levels, especially 
since following infection the CD11b+ numbers and IL-23 levels became comparable 
between the genotypes. With respect to IL-5, CISH has been previously implicated in 
triggering eosinophil activation and subsequent increase in IL-5 levels. (Yang et al., 
2013). However, infection with P. berghei ablated this difference in IL-5 levels, but 
interestingly IL-5 was significantly elevated in infected male Cish-/- mice. Infection of 
the female Cish-/- mice did, however, lead to the significant elevation of macrophage-
attracting chemokines MCP-1, MCP-3, MIP-1 and MIP-1 relative to Cish+/+ females. 
These chemokines act to regulate leukocyte trafficking and deploy immune cells to 
peripheral sites of pathogen challenge and inflammation. How these impact on 
hematopoiesis in the Cish-/- mice, if at all, remains unclear since male mice of both 
genotypes exhibited similar induction of these chemokines.  
In summary, Cish-/- mice exposed to an acute malaria infection did not exhibit 
an increased susceptibility to succumb to severe malaria anemia. It remains to be 
ascertained whether a chronic infection, in which erythropoiesis would be placed under 
greater stress, is required to tease out the potential contribution of CISH to susceptibility 
to severe malaria anemia. This similar susceptibility was despite an altered basal 
erythropoiesis in these mice, particularly in females, which may be due to reduced 
STAT5 activation. How an absence of CISH leads to this effect remains an intriguing 
question. The uninfected female Cish-/- mice also displayed enhanced granulopoiesis, 
in keeping with a role for STAT5 in this pathway. Finally, specific chemokines released 
by monocytes were found to be increased following infection in the female Cish-/- mice. 
Further investigation using this Cish-/- mouse model could shed more light on what 
impact this might play on effector cells and potentially inflammatory diseases.









Investigation of the role of CISH in 





Cerebral malaria represents one of the most severe pathologies of malaria 
infection. It has been extensively studied using the experimental cerebral malaria 
(ECM) model that is based on P. berghei ANKA infection in C57Bl/6 mice (de Oca et 
al., 2013) and is associated with elevated levels of pro-inflammatory cytokines and 
chemokines (Hanum et al., 2003). Members of the Suppressor of Cytokine Signaling 
(SOCS) protein family have been previously implicated in the regulation of cytokines, 
including inflammatory cytokines (O'Sullivan et al., 2007, Wormald and Hilton, 2004), 
with SOCS-1 identified as being activated in ECM (Bullen et al., 2003). A SNP in the 
gene encoding the SOCS family member CISH has been implicated in malaria-
associated morbidity (Khor et al., 2010). To investigate whether CISH does indeed play 
a role in the susceptibility of the host to ECM, a comparative study was performed in 
Cish+/+ and Cish-/- mice in which the outcome of infection with P. berghei ANKA was 
analysed. In addition, a detailed analysis of serum cytokine and chemokine responses 
was also performed.   
5.2 Results 
5.2.1 Susceptibility to ECM 
In an initial infection experiment, a dosage of 1×106 P. berghei-pRBCs was 
administered intraperitoneally to six-week-old female and male Cish+/+ and Cish-/- 
littermates that were humanely culled upon reaching ECM-related endpoints. Body 
weights were recorded before infection (day 0) and then daily from 3 d.p.i. The 
percentage change in the body weight compared to the initial weight of each mouse was 
plotted over time (Fig. 5.1.A, left panel).  
Both Cish+/+ and Cish-/- females had comparable initial weights, and did not 
begin to lose substantial weight until after 3 d.p.i. The female Cish-/- mice lost slightly 
less weight than the Cish+/+ mice at 5 and 6 d.p.i., but this was not statistically 
significant (p=0.11). The Cish-/- males began to lose weight from 5 d.p.i., which was 







Figure 5.1: Comparison of ECM outcome in Cish+/+ and Cish -/- mice infected with 
P. berghei  
Females (left panel) and males (right panel) were infected with 1×106 P. berghei 
ANKA parasitized RBC. Body weights were measured daily and presented as change 
in body weight compared to day 0 (A). Parasitaemias were determined daily from 3 
d.p.i (B). ECM symptoms were scored daily and mice humanely culled upon reaching 
appropriate endpoints displayed as survival curves (C). The cumulative data are derived 
from two independent infections, with four to six mice per group except in the case of 
the Cish+/+ male, in which only one mouse could be included in this experiment. Error 




Only one male Cish+/+ mouse was born from the litters available, which 
prevented robust comparison between genotypes for males, although the response of 
this mouse was comparable to the Cish-/- males. The level of parasitemia was also 
measured during the course of infection from 3 d.p.i. (Fig. 5.1.B). No significant 
difference was observed in the course of parasitemia between the female genotypes 
(Fig. 5.1.B, left panel). Despite Cish-/- males losing less weight compared to their 
female counterparts, the progression of the parasitemia showed similar kinetics (Fig. 
5.1.B, right panel).  
Mice were also scored for their ability to succumb to ECM by examining for 
symptoms such as ataxia, limb paralysis, inability to self-right and presence of seizures. 
Mice were humanely culled when at least three of these symptoms were displayed, 
which was represented as a survival curve. In this experiment, females of both 
genotypes developed symptoms of ECM starting from 6 d.p.i. onwards and by 7 d.p.i. 
all mice had rapidly succumbed to ECM (Fig. 5.1.C, left panel). Similarly, all male 
Cish-/- mice succumbed to ECM in a similar timeframe to the female mice as did the 
single Cish+/+ male mouse (Fig. 5.1.C, right panel). 
It was reasoned that a dose of 1×106 pRBCs may have been too high to tease 
out any subtle contribution of CISH to ECM, since all mouse succumbed to this 
pathology within a very short time frame. Accordingly, the experiment was repeated 
but this time a lower dose of 1×105 P. berghei-pRBCs was used (Fig. 5.2). For this 
experiment, a sufficient number of male Cish+/+ progeny were born to allow complete 
analysis of susceptibility across both sexes.  
Overall the results obtained were comparable to those using a higher dose.  Both 
females and males of both genotypes maintained their body weight for a longer period 
after the infection with the lower dose of pRBCs (Fig. 5.2.A). However, no significant 
difference in weight loss was observed between the genotypes by 7 d.p.i., although 
Cish-/- females had a slightly greater body weight compared to Cish+/+ females (data not 
shown). This is the latest time point at which statistical analysis could be performed 
due to the reduced numbers of mice beyond this time as a result of endpoints being 



















Figure 5.2: Comparison of ECM outcome in Cish+/+ and Cish-/- mice infected with 
a lower parasite dose  
Females (left panel) and males (right panel) were infected with 1×105 P. berghei 
ANKA parasitized RBC. Body weights were measured daily and presented as change 
in body weight compared to day 0 (A). Parasitaemias were determined daily from 3 
d.p.i (B). ECM symptoms were scored daily and mice humanely culled upon reaching 
appropriate endpoints displayed as survival curves (C). Error bars indicate the standard 




There was also no difference in the parasitemia between Cish+/+ and Cish-/- 
females (Fig. 5.2.B, left panel) or males (Fig. 5.2.B, right panel). Moreover, even using 
the lower infection dose, no significant difference in the susceptibility of the mice of 
different genotypes to succumb to ECM was obtained. Since ~40% of animals did not 
develop ECM in this experiment, reducing the parasite dose even further was not 
considered a viable option (Fig. 5.2.C). 
5.2.2 Cytokine and chemokine responses 
Given the importance of inflammatory cytokines in cerebral malaria, serum 
cytokines were also analysed as part of this study. Serum was collected from the initial 
experiment prior to infection (pre-bleeds) and upon culling of mice infected with 1×106 
P. berghei-pRBC (final bleeds) and analysed for pro-inflammatory and anti-
inflammatory cytokines and chemokines.  
Among the pro-inflammatory cytokines, no differences were observed between 
uninfected Cish+/+ and Cish-/- female mice (Fig. 5.3). Only IL-18 significantly increased 
upon infection of female mice, but this was comparable in both genotypes. However, 
Cish-/- males additionally showed significantly increased levels of IFN-, TNF-and 
IL-9 after infection, with a trend for this in female mice of both genotypes for IFN- 
and in wildtype mice for TNF-. In contrast, IL-6 levels were significantly reduced in 
the infected female (and male) Cish-/- mice, but not in Cish+/+ females 
Of the serum chemokines studied, only eotaxin levels were different basally, 
being significantly elevated in Cish-/- females compared to Cish+/+ females, although 
the levels post-infection was similar between the genotypes. IP-10 and RANTES 
increased with infection to a statistically significant extent in both female genotypes 
and in Cish-/- males (Fig. 5.4). Male Cish-/- mice also had significantly increased GRO-
(CXCL1) and macrophage-attracting chemokines MCP-1, MIP-1 and MIP-1, with 
some trend for these in female mice of both genotypes (Fig. 5.4) Interestingly, amongst 
the anti-inflammatory cytokines, only IL-10 and IL-27 showed any significant 
















































Figure 5.3: Comparison of serum pro-inflammatory cytokines in Cish+/+ and      
Cish-/- mice  
Serum was collected prior to infection with 1×106 P. berghei ANKA (pre-bleed) and 
upon culling the mice (final bleed) and analysed for cytokine levels using ELISA (n=4). 
Data represents mean ± SD and statistical significance was measured using One-way 
ANOVA: *p<0.05, **p<0.01, ***p<0.001.  














































Figure 5.4: Comparison of serum chemokines in Cish+/+ and Cish-/- mice 
 Serum was collected prior to infection with 1×106 P. berghei ANKA (pre-bleed) and 
upon culling the mice (final bleed) and analysed for cytokine levels using ELISA (n=4). 
Data represents mean ± SD and statistical significance was measured using One-way 
ANOVA: *p<0.05, **p<0.01, ***p<0.001. 
 
 






















Figure 5.5: Comparison of serum anti-inflammatory cytokines in Cish+/+ and   
Cish-/- mice  
Serum was collected prior to infection with 1×106 P. berghei ANKA (pre-bleed) and 
upon culling the mice (final bleed) and analysed for cytokine levels using ELISA (n=4). 
Data represents mean ± SD and statistical significance was measured using One-way 
ANOVA: *p<0.05, **p<0.01, ***p<0.001.        




  5.2.3 Serum cytokine analysis with a low dose infection 
Serum cytokines were also analysed before and after mice were administered a 
low dose of P. berghei parasites (1×105 pRBCs). This time there were sufficient mice 
available for each genotype and sex (n=6 per each group) to perform statistical analysis. 
Amongst pro-inflammatory cytokines, there were again no differences in basal 
levels between genotypes (Fig. 5.6). However, once more IL-18 was significantly 
elevated following a low-dose infection of both female genotypes, as well as in Cish+/+ 
males, with a non-significance increase in Cish-/- males.  Male Cish-/- mice additionally 
showed a significant increase in IL-9, TNF- and IFN-GM-CSF and IL-17upon a 
low-dose infection that did not reach significance in the male Cish+/+ mice, with the 
post-infection levels of TNF- and IL-17 being significantly higher in Cish-/- males 
compared to their Cish+/+ counterparts.  
For the serum chemokines, basal levels of eotaxin and MCP-3 were 
significantly elevated in the female Cish-/- mice compared to female Cish+/+ mice, but 
were comparable after infection, while there were no differences in the basal levels of 
chemokines between genotypes for the male mice (Fig. 5.7). RANTES and IP-10 levels 
significantly increased upon a low-dose infection in female mice of both genotypes, 
and also in male Cish-/- mice but this did not reach significance in male Cish+/+ mice. 
MCP-1, MCP-3, MIP-1and MIP-1 were also increased significantly in male Cish-/- 
mice but again not in their Cish+/+ counterparts.  
With respect to the anti-inflammatory cytokines, IL-13 basal levels were 
significantly higher in the female Cish-/- mice compared to the female Cish+/+ mice but 
after the low dose infection, the levels of IL-13 were significantly reduced in the       
Cish-/- mice and became comparable to their Cish+/+ counterparts (Fig. 5.8). No 
significant difference was observed in the basal anti-inflammatory cytokine levels in 
the male mice of either genotype. The serum levels of all other anti-inflammatory 












































Figure 5.6: Comparison of serum pro-inflammatory cytokines in Cish+/+ and     
Cish-/- mice after a low dose P. berghei infection 
 Serum was collected prior to infection with 1×105 P. berghei ANKA (pre-bleed) and 
upon culling the mice (final bleed) and analysed for cytokine levels using ELISA (n=6). 
Data represents mean ± SD and statistical significance was measured using One-way 
ANOVA: *p<0.05, **p<0.01, ***p<0.001. 
 
 












































Figure 5.7: Comparison of serum chemokines in Cish+/+ and Cish-/- mice after a low 
dose P. berghei infection 
 Serum was collected prior to infection with 1×105 P. berghei ANKA (pre-bleed) and 
upon culling the mice (final bleed) and analysed for cytokine levels using ELISA (n=6). 
Data represents mean ± SD and statistical significance was measured using One-way 
ANOVA: *p<0.05, **p<0.01, ***p<0.001. 
 
 
















Figure 5.8: Comparison of serum anti-inflammatory cytokines in Cish+/+ and    
Cish-/- mice after a low dose P. berghei infection 
 Serum was collected prior to infection with 1×105 P. berghei ANKA (pre-bleed) and 
upon culling the mice (final bleed) and analysed for cytokine levels using ELISA (n=6). 
Data represents mean ± SD and statistical significance was measured using One-way 
ANOVA: *p<0.05, **p<0.01, ***p<0.001. 
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 5.3 Discussion 
The contribution of CISH to hematopoiesis and immunity still remains to be fully 
elucidated as only limited studies have been performed in Cish knockout mice (Miah 
and Bae, 2013, Delconte et al., 2016, Palmer et al., 2015).  Given the prominent role 
played by cytokines in the pathology of ECM and the fact that CISH is one member of 
the SOCS family of negative regulators of cytokine signaling, investigation into the role 
of CISH in ECM was warranted.  Infection of Cish+/+ and Cish-/- mice on a C57/Bl6 
background with P. berghei provided a unique opportunity to examine the possible role 
of CISH in the proposed susceptibility to severe malaria disease. 
The initial results from this Chapter using a standard infective dose failed to 
identify a difference in the susceptibility of the C57/Bl6 Cish+/+ and Cish-/- mice to 
ECM. Parasitemia, change in body weight and kinetics of ECM induction following 
infection with P. berghei were all comparable between Cish+/+ and Cish-/- mice 
irrespective of sex. However, since the P. berghei-infected wildtype C57/Bl6 mice 
succumbed very rapidly to ECM, it was possible that there was insufficient scope to 
evaluate whether the absence of CISH might exacerbate disease. Therefore, additional 
experiments were performed using a reduced dose of parasitized RBC (by one-log). 
This delayed the onset of ECM in both Cish+/+ and Cish-/- mice, but both succumbed to 
disease at a similar frequency. 
Despite these negative findings, it was nonetheless of interest to examine 
whether perturbed CISH expression impacted on basal serum cytokine and chemokine 
levels and those induced by infection with P. berghei. The role of inflammatory 
responses during ECM is well studied, contributing to severe disease and parasite 
sequestration in blood vessels (Schofield and Grau, 2005). Cytokines such as TNF- 
(Grau et al., 1987) and IFN-γ (Grau et al., 1989a), in conjunction with  effector cells, 
including CD4+ T cells (Yanez et al., 1996), CD8+ T cells (Nitcheu et al., 2003) and 
NK cells  (Hansen et al., 2007) have been shown to contribute to the development of 
ECM. While CISH is not known to be a direct regulator of many of the cytokines that 
are involved in ECM, it is possible that CISH plays an indirect effect in their regulation 
and thus in the pathology of ECM.  
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This study revealed that the basal cytokine and chemokine levels in the Cish-/- 
and Cish+/+ mice were largely comparable, with only a few subtle differences observed 
between genotypes in the female mice. Moreover, in response to an infection, the 
inflammatory responses in both genotypes of either sex were generally in keeping with 
those that have typically been observed as a result of P. berghei infection – and was 
irrespective of whether the mice were administered a low dose or high dose infection. 
Whether the cytokines expressed in local organs such as spleen and brain have a 
different cytokine profile than the serum cytokines are unknown as these were not 
measured as part of this study. However, there were some cytokines and chemokines, 
particularly in the male Cish-/- mice, that were elevated following infection.   
With respect to the pro-inflammatory cytokines, IFN-, TNF-, IL-9, IL-17 and 
GM-CSF were elevated in all male mice in response to infection, but the increases only 
reached significance in the Cish-/- mice, with infected-induced TNF- and IL-17 levels 
in male Cish-/- mice also significantly higher when compared to infected Cish+/+ mice. 
Of these five inflammatory cytokines, TNF- and IFN have been previously been 
associated with disease severity (Schofield and Grau, 2005) and CISH is induced by 
both of these cytokines (Wang et al., 2011b). During an infection, IFN-γ is produced 
largely by natural killer (NK) and natural killer T (NKT) cells to exert an innate immune 
response (Artavanis-Tsakonas and Riley, 2002, Miller et al., 1993, Miller et al., 
2014),as well as by CD4+ Th1 and CD8+ cytotoxic T lymphocyte (CTL) effector cells 
(Schoenborn and Wilson, 2007). TNF- is also produced by NK cells (Caron et al., 
1999), CD4+ and CD8+ T lymphocytes (Brehm et al., 2005) as well as by eosinophils 
(Costa et al., 1993) and other cells such as neutrophils and mast cells (Feiken et al., 
1995, Lilja et al., 2000). In addition, IFN-γ-producing CD4+ T cells are also able to 
promote ECM by controlling CD8+ T cell accumulation within the brain (Villegas-
Mendez et al., 2012), where they are known to be responsible for the development of 
ECM (Nitcheu et al., 2003, Belnoue et al., 2002). NK cells also stimulate the expression 
of chemokine receptor CXCR3 on Th1-type CD4+ T cells and effector CD8+ T cells in 
the brain of mice that have succumbed to ECM after a P. berghei  infection (Hansen et 
al., 2007) and stimulate the DC-mediated priming of naïve CD8+ T cells (Ryg-Cornejo 
et al., 2013). Two very recent studies have shown increased NK cells and CD8+ T 
lymphocyte activity in the absence of CISH (Delconte et al., 2016, Palmer et al., 2015). 
CISH acts as a negative regulator of IL-15 signaling, which normally regulates NK cell 
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homeostasis. The deletion of CISH thus rendered NK cells hypersensitive to IL-15, 
leading to their enhanced survival and proliferation (Delconte et al., 2016). CISH has 
also been shown to actively silence T cell receptor signaling in CD8+ T cells to maintain 
tumour tolerance, inhibiting CD8+ T cell expansion, functional avidity, and cytokine 
poly functionality such that its deletion or knock-down augments CD8+T cell anti-
tumour immunity (Palmer et al., 2015). Unfortunately, in our study herein, the cellular 
responses including that of NK cells, CD4+ and CD8+ T cells was not examined, nor 
were the levels of IL-15 measured and thus in future studies it would be interesting to 
compare IL-15 levels and the numbers of NK cells in the Cish+/+and Cish-/- mice after 
P. berghei infection and the infiltration of CD8+ T cells in the brains. Although the 
differences may be subtle given the Cish+/+ and Cish-/- mice suffered a similar fate, they 
may be sufficient to elevate the production of IFN-  and TNF- production in Cish-/-
mice.  
It was also interesting to observe that GM-CSF, IL-17 and IL-9 were elevated 
in the male Cish-/- mice during infection. GM-CSF is produced by several cell types, 
including CD4+ T and CD8+ T cells (Herndler-Brandstetter and Flavell, 2014, Min et 
al., 2010), B cells, monocytes/macrophages and endothelial cells (Shiomi and Usui, 
2015) and its production is stimulated by TNF-. Although GM-CSF is well known to 
trigger the JAK2/STAT5 pathway (Hamilton, 2008) and induce the production of CISH 
(Yoshimura et al., 1995), GM-CSF deficient mice have relatively normal myelopoiesis 
(Stanley et al., 1994), indicating this factor plays a redundant role in myeloid cell 
development. However, this cytokine appears to have many pro-inflammatory 
functions and the pathogenicity of the CD4+ T cell subset Th17, which also produces 
IL-17 is associated with their production of GM-CSF (Codarri et al., 2011, Villeval et 
al., 1990a, El-Behi et al., 2011). IL-9 also induces the differentiation of CD4+ T cells 
into TH17 cells (Elyaman et al., 2009). Although Th17 cells have been shown to be 
activated during a Plasmodium infection, so far they have not been shown to have a 
defined role in ECM (Perez-Mazliah and Langhorne, 2014).  
In female mice, the pro-inflammatory cytokine responses were less marked than 
in the male mice and only IL-18 levels were significantly elevated during infection and 
this was observed in both genotypes. IL-18 responses also increased in the male mice 
but this was only significant for the male Cish+/+ mice. The relevance of the increase in 
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IL-18 during infection is unclear as IL-18 has been shown to be dispensable for the 
induction of ECM (Kordes et al., 2011). 
The contribution of many chemokines to ECM is also well documented. 
However, the role of CISH in the regulation of chemokines is far from understood. IP-
10 levels along with RANTES were elevated in infected females of both genotypes, 
however their elevation in male mice was only significant for the Cish-/- mice. Elevated 
levels of IP-10 (interferon gamma induced protein) (CXCL10) has been associated with 
ECM in P. berghei infected mice (Wilson et al., 2013), as well as in humans (Wilson 
et al., 2011), with IP-10 activating CXCR3, which is crucial in T cell trafficking and 
function during an infection. Typically, low levels of RANTES are associated with 
disease severity in malaria (Casals-Pascual et al., 2006).  Platelets are a major reservoir 
of RANTES in the peripheral circulation (Appay and Rowland-Jones, 2001) and as 
thrombocytopenia is often associated with severe malaria, this could explain why 
RANTES levels are usually low. However, RANTES is also produced by CD8+ T cells 
and in another study, increased mRNA expression of RANTES and its receptor CCR5 
was found in the brains of children who died of CM (Sarfo et al., 2004).  
Other chemokines that were significantly elevated in male Cish-/- mice during 
infection were MCP-1, MCP-3, MIP-1(CCL3 and MIP-1 (CCL4). These 
chemokines are potent chemo-attractants for monocytes and leukocytes, but they also 
regulate macrophage function (Opdenakker et al., 1993, Lehtonen et al., 2002, Biethahn 
et al., 1999). They are produced by macrophages in response to activation of the 
JAK2/STAT5 pathway via GM-CSF (Yamaoka et al., 1998, Lehtonen et al., 2002) and 
IL-3 (Azam et al., 1995). CISH has been shown to be a negative regulator of GM-CSF-
induced STAT5, with the increased levels of chemokines observed potentially related 
to a loss of this negative control, which would be interesting to explore further in these 
mice. However, other cells also produce MIP-1(CCL3 and MIP-1 (CCL4), notably 
CD4+ and CD8+ T cells produce MIP-1 and MIP-1in response to some viral 
infections (Kristensen et al., 2004) and NK cells produce MIP-1 (Bluman et al., 1996). 
Thus, the increase in these chemokines could also be associated with the increased in 
NK and CD8+ T cell activity observed in CISH deficient mice in other studies. 
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For the female mice, the only other chemokines that were elevated specifically 
in Cish-/- mice were basal CCL7 (MCP-3) and eotaxin. However, the levels of these 
chemokines increased in the Cish+/+ mice during infection such that there was no longer 
a significant difference in their levels between genotypes. Eotaxins are strong 
eosinophil chemo-attractants. In a study regarding human airway eosinophils, a 
reduction in STAT signaling increased CISH expression in response to allergy 
(Burnham et al., 2013). Also, CISH is known to be a negative regulator of CD4+ T cell–
mediated allergic responses (Yang et al., 2013). Taken together, the absence of CISH 
could lead to a pre-allergic state causing the increased eotaxin basal levels observed in 
the Cish-/- females. It should be noted that SOCS-1 (another regulator of cytokine 
signaling) also regulates eotaxin (Sato et al., 2004) and is activated in ECM (Bullen et 
al., 2003). This is consistent with the findings of several studies that indicate eotaxin is 
downregulated during malaria and could be involved in pathogenesis (Dieye et al., 
2016), which may explain why eotaxin was not further elevated upon infection of the 
Cish-/- mice. 
Finally, with respect to the anti-inflammatory cytokines, only the level of IL-27 
was elevated in Cish-/- males in response to a high dose (106 pRBC) infection. Whether 
this was dependent of CISH is unknown as there were insufficient Cish+/+ males 
available for comparison. However, with a lower dose of infection (105 pRBC), IL-27 
responses were not significantly increased upon infection in the males of either 
genotype. IL-27 is produced by activated dendritic cells as well as macrophages in 
response to Toll-like receptor ligands and pro-inflammatory cytokines (Liu et al., 2007) 
but the relationship between CISH and the regulation of anti-inflammatory cytokines, 
including IL-27 is not clear.   In the female Cish-/- mice, only the basal level of the anti-
inflammatory cytokine IL-13 was significantly higher compared to the Cish+/+ mice, 
but upon infection its levels were comparable to Cish+/+ mice. IL-13 is secreted by 
activated Th2 cells and is involved in suppressing the secretion of several macrophage 
and monocyte-derived inflammatory cytokines. Along with eotaxin, it is involved in 
allergic responses. IL-13 up-regulates both SOCS1 (Hebenstreit et al., 2003) and CISH 
(Rutti et al., 2016) which constitutes a negative feedback loop.  In the absence of CISH, 
SOCS1 expression may be inhibiting further IL-13 signaling in the infected mice, which 
may be one reason for the decreased IL-13 levels observed in the female Cish-/- mice 
during infection.  
Chapter 5 
 106 
In conclusion, the elevated pro-inflammatory cytokine and chemokine 
responses observed particularly in infected male Cish-/- mice is in keeping with the 
findings that depletion of CISH leads to an increase in NK and T cell activity. However, 
these responses were not sufficient to have an impact on the outcome of the disease. It 
should be noted that in the absence of CISH, other SOCS proteins like SOCS-1, which 
are also involved in the negative regulation of cytokine signaling, could be playing an 
important contribution to cytokine responses and thus it would be interesting to examine 
how their expression is affected in the absence of CISH. 
 


















Anemia in malaria stems from both enhanced erythrocyte destruction as well as 
ineffective erythropoiesis (Lamikanra et al., 2007) but the mechanisms by which 
particularly the latter occurs has been ill-defined to date. This is because there are 
limited studies that have examined the impact of a Plasmodium infection on 
erythropoiesis in the bone marrow. Given the difficulties in undertaking this in patients 
infected with P. falciparum, Chapter 3 of this thesis used a P. berghei infection model 
to examine that changes that occur to erythropoiesis and hematopoiesis more broadly 
in response to an acute infection.   
Consistent with previous findings using the rodent model system, BALB/c mice 
infected with P. berghei succumbed to anemia as evidenced by the low Hb levels in the 
peripheral blood. However, in Chapter 3, it was also revealed that the bone marrow of 
infected mice had a noticeable decrease in bone marrow cellularity. With respect to the 
erythroid lineage, the number and frequency of bone marrow Ter119+ cells significantly 
declined in response to the infection, with each stage of progenitor cell affected. 
Moreover, the relative numbers of BFU-E between 4-6 d.p.i, and the proportion of 
CFU-E by 8 d.p.i were significantly reduced. This suggests that during the infection 
there was insufficient production of RBCs through the increased conversion of CFU-E 
to erythroblasts to prevent anemia (Villeval et al., 1990b). This in turn could have 
triggered the increase in BFU-E observed at 8 d.p.i.  This is unlikely be due to a decline 
in EPO levels since another study has shown that even in the presence of high EPO 
levels, low numbers of CFU-E progenitors could not trigger the efficient production of 
RBCs in turn leading to the production of more BFU-E (Dolznig et al., 2006).  A 
decrease in bone marrow cellularity, bone marrow BFU-E and CFU-E numbers have 
been observed previously in rodent malaria (Maggio-Price et al., 1985). It will be 
interesting in future studies to examine why a depletion of BFU-E was consistently 
observed at 4 - 6 d.p.i, and whether this is being the result of apoptosis, their relocation 
to the spleen, or a shunt away from the erythroid pathway in favour of a myeloid 
response in order to clear the infection Any of these scenarios in turn would result in 
reduced blast populations in the bone marrow, but these possibilities have to be formally 
tested. In the spleen, it has also been shown that stress erythropoiesis is carried out by 
a distinct population of stress erythroid progenitor cells, which differ from the steady 
state progenitors present in the bone marrow (Lenox et al., 2005). This could be 
responsible for the increase in the erythroblasts in the spleen during stress 
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erythropoiesis.  It should also be noted that by the latter stages of the infection (8 d.p.i) 
there was a significant increase in the proportion of CFU-G in the bone marrow, 
indicating this organ was attempting to elicit an erythroid response but in this acute 
model, this response is clearly too late to correct circumvent disease severity. 
The corresponding increase in splenic erythroblast numbers may be an 
indication that BFU-E and CFU-E have migrated to the spleen. In some of the non-
malaria related studies examining blood loss and anemia, it is thought that the reduced 
numbers of BFU-E in the bone marrow was due to their migration to spleen and/or 
differentiation into CFU-E in the marrow (Hara and Ogawa, 1976, Iscove, 1977).  In 
future studies, therefore, it would be interesting to compare the BFU-E and CFU-E 
numbers in the spleen to those in bone marrow during an infection time course. 
Moreover, it would be interesting to see whether apoptosis of HSC or BFU-E in the 
bone marrow is a contributor to anemia in malaria. Nevertheless, despite the increase 
in the splenic erythroblast numbers, the decrease in reticulocytes and RBCs at the latter 
stages of the infection, stemming most likely from the clearance of uninfected and 
infected RBC (Evans et al., 2006), must not be sufficient to compensate for the loss of 
RBC, because the mice succumb to anemia. 
In this study, attempts were also made to measure changes to pSTAT5 levels in 
response to infection, since STAT5 is important in signaling through the EPO receptor. 
No significant changes were observed in the bone marrow, whilst the pSTAT5 levels 
in spleen cells declined by 7 d.p.i. In Chapter 4, the pSTAT5 levels were similarly 
depleted even in the absence of CISH, a negative regulator of STAT5 signaling. It is 
interesting, therefore, that another study has shown that SOCS-1, -2, and -3 are up-
regulated in the spleen in response to P. berghei infection (Sexton et al., 2004), 
suggesting the activation of a negative-feedback loop that may be responsible for 
dampening JAK2-STAT5 signaling.  
Transcription and lineage-specific transcription factors such as GATA-1, FOG-
1, EKLF, SP1, and PU.1 also regulate erythropoiesis and play indispensable roles in 
red blood cell development. In future studies, it would be interesting to see whether the 
expression of these transcription factors change in response to an infection and whether 
they are altered in Cish-/- females, particularly given it could be shown in Chapter 4 that 
these mice displayed noticeable differences in their erythroid and hematopoietic 
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response in comparison to their wildtype counterparts prior to infection. For example, 
the numbers of mature erythroid cells, BFU-Es and CFU-E were all decreased in the 
bone marrow of uninfected female Cish-/- mice; whether this is also the case in the 
spleen is unknown. Intriguingly, this was not the case for the male genotypes.   
The uninfected Cish-/- females also displayed a significant increase in frequency 
of Gr-1+ populations. GM-CSF governs both homeostatic as well as emergency 
development of granulocytes and is regulated by STAT5 (Lehtonen et al., 2002). Of 
note, deficiency in STAT5 results in reduced cytokine-mediated proliferation and 
survival of progenitors as well as of erythroid, lymphoid, and myeloid cells. On the 
other hand, gain-of-function of STAT5 in mice that carry Stat5a/b hypomorphic alleles 
causes excessive granulopoiesis and prolonged survival of granulocytes in circulation 
(Lin et al., 2013). It will be important in future studies to measure STAT5 levels in Gr-
1+, CD11b+ and CD61+ populations in the bone marrow and spleen during an infection 
to help understand how STAT5 levels are maintained when there is a normal balance 
between myeloid and erythroid cells during hematopoiesis and how it is affected by a 
malaria infection. This could also shed light on the increased granulopoiesis but 
decreased erythropoiesis observed in uninfected Cish-/- females.  
The infection of the BALB/c Cish+/+ and Cish-/- mice in Chapter 4 saw a 
significant increase of MCP-1, MCP-3 and MIP-1 levels in the Cish-/- females relative 
to Cish+/+ females. These chemokines are all involved in macrophage trafficking to the 
site of inflammation. It is not known why these chemokines were elevated, given that 
the Gr-1+ and CD11b+ cell populations were similar between infected females of both 
genotypes.  Moreover, despite the other parameters that were different between the 
female genotypes, they were not sufficient to have an impact on the outcome of the 
disease. Interestingly, in Chapter 5 a similar outcome in response to infection was 
observed between both male C57/Bl6 Cish genotypes, despite the fact that the 
uninfected male Cish-/- mice exhibited elevated pro-inflammatory cytokine and 
chemokine responses. However, it is also possible that in the absence of CISH, other 
SOCS proteins like SOCS-1, which are also involved in the regulation of cytokine 
signaling and STAT5 expression, are able to complement CISH function and thus it 




During the course of this thesis, several studies were published that showed 
CISH acts as a negative regulator of IL-15 signaling, which normally regulates NK cell 
homeostasis, and actively silence T cell receptor signaling in CD8+ T cells. The deletion 
of CISH renders NK cells hypersensitive to IL-15, leading to their enhanced survival 
and proliferation (Delconte et al., 2016). CISH also inhibits CD8+ T cell expansion, 
functional avidity, and cytokine poly functionality (Palmer et al., 2015). Unfortunately, 
in our study, the cellular responses including that of NK cells, CD4+ and CD8+ T cells 
were not examined, nor were the levels of IL-15 measured. Given that NK cells and 
CD8+ T cells have been shown to play a critical role in the development of ECM 
(Hansen et al., 2007, Belnoue et al., 2002), it would be interesting to compare IL-15 
levels and the numbers of NK cells and the infiltration of CD8+ T cells in the brains in 
the Cish+/+and Cish-/- mice after P. berghei infection.  
Nevertheless, any difference between the genotypes in the NK and CD+ T cells 
that may have been present in the brains of the Cish-/- mice C57/Bl6 mice were 
insufficient to increase their susceptibility to succumb to ECM after infection with P. 
berghei. The parasitemia and percentage changes in body weight after infection were 
comparable between the Cish-/- and Cish+/+ mice, irrespective of their sex and the ability 
of the mice to survive the infection was also similar between the genotypes. With a dose 
of 1×106 iRBCs, C57/Bl6 mice succumbed very rapidly to ECM, making it difficult to 
assess whether depletion of CISH played any additional contribution to the demise of 
the mice. Reduced dose of parasitized RBC (1×105) was administered to the mice to 
delay the onset of ECM in order to tease out whether CISH plays a subtle role in 
susceptibility to ECM. However, this did not influence the results and instead some of 
Cish-/- and Cish+/+ mice no longer succumbed to disease.  
Five SNPs in CISH have been associated with increased susceptibility of 
humans to infectious diseases, with the risk of tuberculosis, severe malaria or bacterial 
septicaemia increasing by 18% (Khor et al., 2010). While IL-2 determines the 
magnitude of T-cell response during an infection, CISH regulates IL-2 signaling (ref 14 
in journal); the SNP in CISH are hypothesized to cause variability in IL2 signaling 
leading to excessive cytokine-mediated inflammatory responses that lead to severe 
malaria and sepsis. In this study, Cish-/- mice were compared for their susceptibility to 
malaria against Cish+/+ mice. However, no differences were observed in the 
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susceptibility to malaria. As CISH belongs to a family of SOCS proteins that are known 
to have both overlapping and non-overlapping functions and which can influence 
cytokine signalling (Piessevaux et al., 2006), it is possible that complete deletion of cish 
in mice has led to compensation by other SOCS proteins. It would thus be interesting 
to study the susceptibility to severe malaria in a mouse model in which cish can be 
conditionally knocked down to rule out complementation by other SOCS proteins. It 
would also be worthwile to study the susceptibility of Cish-/- mice in a chronic infection 
model, given that the significant differences in erythropoiesis and cytokine expression 
between the genotypes may alter their ability to cope under the stress of repeated or 
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